Intracellular Voyeurism: Examining the Modulation of Host Cell Activities by <i>Salmonella enterica</i> Serovar Typhimurium
JASON SZETO1 AND JOHN H. BRUMELL1,2*
[SECTION EDITOR: BRETT FINLAY]
Posted July 25, 2005
Infection, Immunity, Injury, and Repair Program, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8,1 and Department of Medical Genetics and Microbiology, University of Toronto, #4388, Medical Sciences Building, 1 King's College Circle, University of Toronto, Toronto, Ontario, Canada M5S 1A82
*Corresponding author. Phone: (416) 813-7654 ext. 3555, fax: (416) 813-5028, E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Salmonella spp. can infect host cells by gaining entry through phagocytosis or by inducing host cell membrane ruffling that facilitates bacterial uptake. With its wide host range, Salmonella enterica serovar Typhimurium has proven to be an important model organism for studying intracellular bacterial pathogenesis. Upon entry into host cells, serovar Typhimurium typically resides within a membrane-bound compartment termed the Salmonella-containing vacuole (SCV). This specialized compartment is essential for proper bacterial replication and survival. From the SCV, serovar Typhimurium can inject several effector proteins that subvert many normal host cell systems, including endocytic trafficking, cytoskeletal rearrangements, lipid signaling and distribution, and innate and adaptive host defenses. The study of these intracellular events has been made possible through the use of various imaging techniques, ranging from classic methods of transmission electron microscopy to advanced live-cell fluorescence confocal microscopy. In addition, DNA microarrays have now been used to provide a "snapshot" of global gene expression in serovar Typhimurium residing within the infected host cell. Here, we describe key aspects of Salmonella-induced subversion of host cell activities, providing examples of imaging that have been used to elucidate these events.
Salmonellae are facultative intracellular pathogens responsible for several diseases. Salmonella enterica serovar Typhimurium is able to infect a broad host range, causing gastroenteritis in humans and a systemic disease in mice that resembles typhoid fever (210). This organism must remodel or subvert various host cell systems to create an intracellular environment that is amenable to its survival. As such, serovar Typhimurium has proven to be an important model organism for studying intracellular pathogenicity.
Many Salmonella virulence genes have been identified, and it is estimated that at least 4% of the serovar Typhimurium genome is required for full virulence of this pathogen in mice (14). A large number of these genes are contained within large gene clusters termed Salmonella pathogenicity islands (SPIs) (83, 96, 97, 141). Similar to other pathogenicity islands, SPIs possess a lower G + C content than the rest of the chromosome. This suggests that SPIs consist of foreign DNA acquired by horizontal transfer from phages, transposons, or other sources (96, 141). Central to the virulence of serovar Typhimurium are type III secretion systems (TTSS), which are specialized needlelike structures that span both the inner and outer bacterial membranes. With these delivery systems, serovar Typhimurium injects an arsenal of virulence proteins (called effectors) into the host cell cytosol to modulate specific host cell processes (Table 1). In this review, we will focus on some of the key aspects of Salmonella intracellular pathogenicity, in particular, the modulation of host cell processes by type-III-secreted effector proteins.
Table 1Proteins secreted by serovar Typhimurium type III secretion systems |
Serovar Typhimurium employs two TTSS, encoded separately in SPI-1 and SPI-2 (67, 82, 100). Genes within SPI-1, located at centisome 63, are needed for invasion of epithelial cells and are expressed in growth conditions that mimic the extracellular environment typical of the intestinal lumen, including high osmolarity and slight alkalinity (2, 67, 69). Typical of other TTSS, some of the proteins secreted by the SPI-1 TTSS (e.g., PrgI) serve a structural role and form part of the syringelike secretion apparatus itself (68). Detailed electron micrographs show that this complex consists of a cylindrical base that resides in the bacterial envelope, from which a needlelike projection originates (Fig. 1) (126, 143). The reader is also directed to other reviews for more comprehensive discussions of TTSS in Salmonella and in other bacteria (38, 44, 68, 106).
To permit the transfer of bacterial proteins into the host, a subset of secreted proteins (e.g., SipB and SipC) act to form a pore, or translocon, in the host cell membrane (31). Other SPI-1 TTSS-secreted proteins, termed effectors, are subsequently injected into the host cell cytosol through the bacterial secretion apparatus and translocon. These effectors can modulate a variety of host cell responses that facilitate bacterial entry into the host, including actin remodeling, membrane ruffling, and phosphoinositide metabolism (see below) (19, 53, 70). Similarly, components of the translocon can also serve as effectors to modulate host cell machinery on their delivery into the host cell. Invasion by Salmonella is therefore quite distinct from classical, receptor-mediated phagocytosis and can be more appropriately described as a "forced feeding" of the host cell (25).
Some TTSS-secreted proteins also require specific chaperones to ensure their proper delivery into the host cell. Chaperones may achieve this through several mechanisms, such as stabilizing their respective TTSS substrates in the bacterial cytosol, optimizing the presentation of secretion signals on these TTSS substrates, or even regulating the expression of TTSS proteins and other virulence genes (58, 175). It has also been proposed that TTSS chaperones may help establish a hierarchy of secretion to ensure that temporal control of TTSS components and effectors is maintained (9). The multifunctional nature of TTSS chaperones is illustrated by the serovar Typhimurium SicA protein, which acts as a chaperone for the secreted translocon components SipB and SipC (212). In a serovar Typhimurium sicA mutant, SipB and SipC are unstable and degraded, indicating a role for SicA in providing stability to its protein substrates (212). SicA may also act to partition SipB and SipC in the bacterial cytosol, thus preventing their premature association. Furthermore, this chaperone appears to function with the InvF transcriptional regulator to activate several virulence genes, including sipB, sipC, sigD, sptP, and sicA itself (47, 48).
Most of the serovar Typhimurium population that enters host cells resides within a membrane-bound compartment termed the Salmonella-containing vacuole (SCV) (54, 123, 207). SPI-2 TTSS genes, located at centisome 31, are expressed inside the SCV and are essential for intracellular replication and systemic infection of mice (see below for a more detailed discussion of SPI-2 gene expression) (39, 99, 171, 172, 179, 192). While expression of genes encoded within SPI-1 is downregulated after invasion, SPI-1 and SPI-2 are not mutually exclusive, and there is evidence that some interaction exists between the two. Since SPI-2 genes are not induced until several hours after invasion, certain SPI-1 effectors may be needed to establish a permissive intracellular niche for serovar Typhimurium. Indeed, although usually associated with host cell invasion, the SPI-1 TTSS is required for maximal intracellular replication (197). Moreover, some effectors, such as SopD, SseK, and SspH1, appear to be secreted by both SPI-1 and SPI-2 TTSS (22, 130, 157).
Recently, the SPI-1 effector SigD has been shown to persist within infected cells at time points long after the initial invasion event (>12 h) (52). SigD was detected at these late time points in RAW 264.7 macrophages infected with wild-type serovar Typhimurium by using immunoblotting methods and by monitoring Akt serine/threonine kinase activity and downstream iNOS production, both of which are stimulated by this effector (52, 198). SigD transcript levels, as well as transcripts of the SPI-1 TTSS structural gene prgI and SPI-1 regulator invF, were detectable in serovar Typhimurium several hours after invasion. Hence, SPI-1 effectors, and presumably the SPI-1 TTSS, can modulate host cell activities even after the induction of SPI-2 genes (52). Studies have also demonstrated that certain SPI-2 gene mutations result in abrogation of SPI-1 gene expression, including those encoding the translocon protein SipC and the SPI-1 transcriptional activator HilA (50, 98). Hence, while serovar Typhimurium SPI-1 and SPI-2 TTSS are often associated with distinct purposes, a temporally coordinated functional overlap may exist between the two secretion systems.
While some TTSS effectors are encoded within their respective SPI-1 and SPI-2 pathogenicity islands, many are encoded elsewhere on the chromosome, including other SPIs (e.g., SPI-5), or within lysogenized phages (15, 120, 141, 172, 222). There is no conserved amino acid sequence or motif common to all TTSS effectors that would direct their translocation (106). However, a subset of effectors that are members of the Salmonella Translocated Effector (STE) family (Table 1) have been shown to contain a conserved N-terminal region within the first 150 amino acids that serves as a translocation signal for SPI-1 and SPI-2 effector delivery into the host cell (22, 156). Other factors that regulate TTSS effector translocation may involve mRNA signals within the encoded effector genes themselves and/or involvement of dedicated chaperones (58, 79, 175). Serovar Typhimurium can also secrete the plasmid-encoded, actin-depolymerizing SpvB toxin in a SPI-1 and SPI-2 TTSS-independent manner, suggesting yet another route by which this pathogen can introduce virulence proteins into the host cytosol (80).
Serovar Typhimurium has a broad host range and can infect both phagocytic and nonphagocytic cells, thus serving as a prototypical model for Salmonella invasion and intracellular parasitism (23). Typically, this pathogen enters the host by oral ingestion and breaches the intestinal epithelia to promote systemic disease. Like many other pathogens, a major route of entry across the intestinal barrier appears to occur through M cells. These specialized epithelial cells line the intestinal lumen at Peyer’s patches through which antigens traverse to the basolateral side and are delivered to antigen-presenting cells (115, 167, 196). The absence or poor development of protective mucous and glycocalyx layers may also make M cells attractive portals for pathogen entry (196). By interacting with macrophages and dendritic cells found underneath M-cell layers, serovar Typhimurium can be transported to other locations such as the liver, spleen, and bone marrow to cause systemic infection (59, 145, 183, 189, 204, 217).
Noninvasive serovar Typhimurium SPI-1 mutants can still breach the intestinal barrier in an M-cell-independent manner, a process that requires CD18-expressing phagocytes (217). Dendritic cells may facilitate this mode of entry since they are able to extend dendrites between absorptive epithelial cells without disrupting the epithelial barrier itself. As a result, dendrites sampling the intestinal lumen for antigens provide another conduit for serovar Typhimurium entry (167, 182, 204). Furthermore, Salmonella may traverse the intestinal barrier by direct invasion of columnar absorptive cells (137, 153).
Invasion of nonphagocytic cells by serovar Typhimurium in vitro is a SPI-1-dependent process (40, 69). SPI-1 is essential for promoting intestinal infection and subsequent gastroenteritis since serovar Typhimurium SPI-1 mutants are attenuated for virulence when delivered orally to mice. However, these mutants retain virulence when administered intraperitoneally, indicating a role for SPI-1 in the invasion and traversal of gastrointestinal epithelial cells by serovar Typhimurium, but not in the systemic phases of disease (69).
Entry of serovar Typhimurium into epithelial cells is characterized by dramatic host cell surface membrane ruffling that drives bacterial uptake (Fig. 2) (68, 70). To date, the contributions of six serovar Typhimurium SPI-1 TTSS effectors involved in invasion have been examined. These effectors include SopE, SopE2, SopB/SigD (herein referred to as SigD), SptP, SipA, and SipC (68). These effectors have been shown to localize to the host cell plasma membrane ( 32). However, SipC is the only member that contains a potential sequence, specifically a central hydrophobic region, that might allow its insertion into host cell membranes (190). The remaining effectors likely associate with the host cell membrane by interacting with resident membrane-associated components.
SopE, SopE2, and SigD are involved in remodeling host actin near the cell surface to produce the characteristic membrane ruffles that precede bacterial entry (Fig. 3). SopE and SopE2 function as guanine nucleotide exchange factors that activate important regulators of actin cytoskeleton assembly, namely, the Rho family GTPases Cdc42 and Rac-1 (3, 63, 89, 201). In turn, downstream effector proteins of the GTPases, such as N-WASP and WAVE, are recruited to membrane ruffles to mediate Arp2/3-dependent actin nucleation (214). Consistent with their role in promoting membrane ruffling, both SopE and SopE2 have been localized along the tips and length of filopodial extensions in fibroblasts infected with serovar Typhimurium or in fibroblasts transfected with genes encoding either effector (32). While the exact mechanism of Rho GTPase activation by Salmonella effectors is not clear, structural studies have provided some insight into this process. The crystal structure of SopE complexed with Cdc42 has recently been obtained and showed that conformational changes in the switch I and II regions of Cdc42 are induced by SopE binding, which may promote guanine nucleotide exchange and activation (30). Similarly, nuclear magnetic resolution (NMR) studies have indicated that SopE2 may also induce conformational changes in the nucleotide-binding region of Cdc42 to promote nucleotide exchange (226).
In contrast to SopE and SopE2, SigD is not a nucleotide-exchange factor but can still activate Cdc42 and stimulate actin assembly by an unknown mechanism (234). SigD possesses phosphoinositide phosphatase activity (142, 169, 234) and it is increasingly apparent that phosphoinositides play critical roles in modulating actin assembly and actin-regulatory proteins (206, 229). Using a chimeric protein composed of the pleckstrin homology domain of phospholipase Cδ and green fluorescent protein (GFP), Terebiznik et al. (208) visualized phosphatidylinositol-4,5-bisphosphate [PtdIns(4,5)P2] in serovar Typhimurium-infected cells. This phosphoinositide was found to be enriched at the outermost regions of membrane ruffles but not at their bases where plasmalemmal invagination occurred (Movie 1). SigD was found to be responsible for the elimination of PtdIns(4,5)P2 at these invagination sites and for promoting membrane fission to facilitate bacterial entry, indicating that the hydrolysis of PtdIns(4,5)P2 is required for Salmonella entry (208). This is consistent with previous studies suggesting a general requirement for PtdIns(4,5)P2 depletion at sites of phagocytosis and endocytosis (12, 118).
Two SPI-1 effectors, SipA and SipC, appear to have cooperative roles in nucleating and stabilizing actin polymers required for membrane ruffling during bacterial invasion (93, 150). By cross-linking actin monomers, it is proposed that SipA reduces the critical concentration of actin needed for polymerization and stabilizes F actin (136, 160, 237). SipA also complexes with and promotes the actin-bundling activity of T plastin at the site of bacterial–host contact (235). Furthermore, SipA has recently been shown to interfere with the actin-depolymerizing proteins ADF/cofilin and gelsolin (149). Thus serovar Typhimurium translocates effectors into the host cell that not only trigger actin polymerization but also counteract the major F-actin-destabilizing proteins (70).
Serovar Typhimurium can also reverse the actin rearrangements that it induces (70). The SPI-1 TTSS effector SptP functions as a GTPase-activating protein for Cdc42 and Rac-1, converting the latter two proteins into inactive GDP-bound forms. As a result, normal actin architecture is restored at the site of bacterial entry and membrane ruffling ceases (64, 65). To help temporally regulate actin assembly and disassembly during invasion, serovar Typhimurium has exploited the host cell ubiquitin-mediated proteasome degradation pathway. While SopE is rapidly ubiquitinated and degraded when introduced into host cells, SptP is much more stable (125). This difference in stability is determined by the N-terminal secretion and translocation domain found in each protein. The half-life of SopE was significantly increased when fused to this N-terminal domain of SptP, while the opposite was observed with a SptP fusion to the secretion and translocation domain of SopE (125). Hence, the persistence of SptP compared with the relatively short-lived SopE likely ensures that SopE-induced actin rearrangements at the site of serovar Typhimurium entry can be restored to normal.
Our understanding of Salmonella invasion continues to evolve, in part, because of a recent focus on this process using polarized epithelial cells. One study determined that Rac activation, not Cdc42, was required for invasion of the apical surface of polarized MDCK cells (45). By contrast, during basolateral invasion both Rac and Cdc42 were activated but neither was required for bacterial entry (45). Thus, invasion of the apical and basolateral surface occurs by distinct mechanisms. Another recent study demonstrated a role for the SPI-1 effectors SopA and SopD in the invasion process (181). Baumler and colleagues complemented a noninvasive mutant (lacking sipAsopABDE2) with plasmids expressing different SPI-1 effectors (181). They demonstrated for the first time that SopA and SopD contribute to Salmonella invasion; however, the apparent role of SopA and SopD could only be detected in polarized epithelial cells.
After internalization, Salmonella cells reside within a membrane-bound compartment termed the Salmonella-containing vacuole (Fig. 4) (54, 123, 207). Here, induction of SPI-2 gene expression ensues, which is essential for intracellular growth of serovar Typhimurium (39, 123, 222). Expression of SPI-2 genes requires the SsrA-SsrB two-component regulatory system which is, in turn, activated by the OmpR-EnvZ two-component system (39, 76, 133). Various studies have shown that environmental changes, such as low pH and osmolarity, and low concentrations of Mg2+, Ca2+, or phosphate, can activate SPI-2 gene expression (49, 76, 133, 155). These conditions may reflect those encountered by serovar Typhimurium within the nascent SCV. Some of the environmental factors that induce SPI-2 genes (e.g., pH and osmolarity) are dissimilar to those that stimulate SPI-1 genes, likely ensuring that the correct TTSS is activated at the proper time (2, 49, 76, 133, 155).
Aside from SPI-2 gene expression, many other genes must also be activated to allow intracellular growth of Salmonella. The PhoP-PhoQ two-component regulatory system responds to low Mg2+ and acts as a master regulator of at least 40 serovar Typhimurium genes necessary for intracellular survival (1, 72, 81). PhoP-PhoQ signaling activates mgtC gene expression, which is involved in Mg2+ acquisition and is required for intracellular replication and virulence in mice (10). Genes that confer resistance to antimicrobial peptides produced by the host cell, as well as genes that modify bacterial lipopolysaccharide (LPS), are also under the control of the PhoP-PhoQ two-component system (57, 86, 193, 194). Furthermore, the PhoP-PhoQ regulon appears to play a role in inhibiting fusion of lysosomes with the SCV, thus contributing to the intracellular survival of Salmonella (78).
Using techniques such as in vivo expression technology (IVET) and random chromosomal insertion of promoterless reporter genes, several studies have attempted to determine which serovar Typhimurium genes may be upregulated after host cell invasion (95, 179). Not surprisingly, most genes identified in these studies are located in pathogenicity islands. Recently, the complete transcriptional profile of serovar Typhimurium following macrophage infection has been obtained by using DNA microarray analyses, representing the first global survey of bacterial gene expression within a host cell system (56). Of the 4,451 coding sequences examined, 919 exhibited significant changes in expression within a macrophage cell line, with 384 genes upregulated and 535 genes downregulated (56). As expected, SPI-2 genes were induced, while SPI-1 gene expression was reduced after invasion. In addition, genes involved in LPS biosynthesis and those encoding flagellin and fimbriae were downregulated, possibly to avoid recognition of serovar Typhimurium surface structures by the immune system (56). By examining the gene-expression profiles it was possible to deduce that the SCV is likely low in Mg2+, Fe2+, and phosphate, but high in potassium and Fe3+ (56). Serovar Typhimurium does not seem to be starved of amino acids since genes responsible for amino acid biosynthesis were not upregulated. Evidence of using the Entner-Doudoroff pathway and gluconate as a carbon source in the SCV was found (56). Significantly, 408 genes of unknown function had altered expression upon invasion of macrophages, further highlighting the complexity of the serovar Typhimurium response to the host cell environment (56).
One of the challenges of elucidating the mechanisms of serovar Typhimurium pathogenesis has been the heterogeneous nature of its intracellular niche in host cells examined in vitro. Studies have indicated that there are at least two distinct populations of intracellular serovar Typhimurium, namely static (or slow growing) and rapidly growing cells (8, 29). Also, it has recently been found that a small but significant fraction of internalized serovar Typhimurium are not present within SCVs and do not colocalize with typical SCV markers such as LAMP-1 (6, 27). Studies in dendritic cells have revealed that a certain proportion of intracellular serovar Typhimurium do not express SPI-2 genes (111). Since SPI-2-encoded proteins are important for intracellular survival (123, 222), this differential expression of SPI-2 in a given population of serovar Typhimurium may account for the observed intracellular heterogeneities. However, most internalized serovar Typhimurium cells reside in SCVs and replicate within these compartments. This population has been the subject of most studies and will be discussed in the following sections.
Unlike classic phagosomes, Salmonella growth and replication is permitted within the SCV (74, 123, 189). During the early stages of its development, the nascent SCV closely resembles a phagosome as it acquires protein markers typically associated with phagosome maturation. These include the GTPase Rab5, implicated in directing early endocytic vesicle trafficking, transferrin receptor, phosphatidylinositol-3-phosphate [PtdIns(3)P], and early endosome antigen 1 protein (EEA1) (166, 176, 191, 199, 221). Similar to phagosomes, these markers remain on the SCV for only a brief period after infection. The rapid recycling of these early endosomal markers from the SCV suggests that the initial dynamics of SCV maturation closely resemble those of nascent phagosomes.
It is established that the dissociation of early endosomal markers from the SCV is followed by the acquisition of a subset of proteins typically associated with late-endocytic and lysosomal compartments. These include Rab7, vacuolar ATPase (vATPase), CD63, and lysosomal glycoproteins (Lgps) LAMP-1 and LAMP-2 (26, 73, 151, 199). While there has been one report of fusion occurring between the SCV and lysosomes (173), it is now generally accepted that survival of bacteria within the SCV is attributed to its uncoupling, or segregation, from the normal route of the host endosomal pathway (20, 28, 73, 92, 108). SCV-lysosomal fusion appears to be impaired in infected macrophages (28, 46, 92, 108). Furthermore, there is a delay in the interaction between the SCV and late-endocytic compartments in epithelial cells (26). Evidence of impaired lysosomal fusion with the SCV is the reduced recruitment of the lysosomal hydrolase cathepsin D and mannose 6-phosphate receptor (MPR; responsible for trafficking hydrolases to the lysosome) on the SCV during the first few hours (~3 h) after infection (73, 151).
What dictates the appearance of a specific subset of late-endosomal/lysosomal markers on the SCV is not known. It has been shown that serovar Typhimurium can promote the clustering of Rab7- and Lgp-enriched, but cathepsin D- and MPR-deficient, vesicles around the SCV within the first hour of invasion ( 151). Hence, it seems that serovar Typhimurium can divert the normal trafficking of specific vesicles to provide a source of Rab7 and LAMP proteins, but not cathepsin D and MPR, to the SCV. While the nature and origin of such vesicles is currently unknown, they may represent intermediate compartments that normally connect late endosomes to lysosomes in the late-endocytic pathway (151). The SPI-2 effector SpiC has been shown to interfere with global intracellular trafficking, including endosome–endosome and phagosome–lysosome fusion events (213), and may play a role in regulating the interactions that occur between the SCV and host cell vesicle traffic.
While its recruitment is impaired at early times after infection, cathepsin D is eventually localized to the SCV at later time points (>3 h), suggesting fusion of the SCV with another subset of late-endocytic compartment may occur with delayed kinetics (26). Similarly, the late-endosome-specific lipid lysobisphosphatidic acid (LBPA) is also acquired by the SCV at late time points after infection (26). Why serovar Typhimurium would permit hydrolytic components such as cathepsin D to be recruited to SCVs is unclear. However, analyses of purified SCV compartments have indicated they preferentially retain unprocessed, inactive forms of cathepsin D (92, 144, 158).
The delayed interaction between the SCV and late-endocytic compartments is intriguing since the GTPase Rab7, which normally modulates transport between late endosomes and lysosomes, is also localized to the SCV. SCV-associated Rab7 still appears to be functional based on its cycling dynamics, as demonstrated by fluorescent recovery after photobleaching (FRAP) experiments (Fig. 5) (144). Expression of a dominant negative Rab7 slows LAMP-1 acquisition by the SCV but does not impair the recruitment of earlier endosomal markers, further implicating the importance of active Rab7 in directing SCV maturation (151).
Several hours (>5 h) after its formation, the SCV undergoes SPI-2-dependent extensive tubulation to produce structures termed Salmonella-induced filaments (Sifs) that emanate from the bacterial compartment (5, 18, 75, 200). These unique structures likely represent the delayed fusion of the SCV with late-endosomal compartments, since several late-endosomal markers are found on Sifs, including LAMP-1, LAMP-2, Rab7, LBPA, and cathepsin D (Fig. 6 and 7) (18, 26, 75, 90). Sifs are more easily visualized in nonphagocytic cell lines, such as epithelial cells. It is likely that the tubular-vesicular nature of lysosomal structures normally found in macrophages may mask Sif structures in these particular cell lines. However, Sif-like structures have recently been observed in gamma interferon (IFN-γ)-primed murine macrophages infected with serovar Typhimurium expressing a HA-tagged SPI-2 TTSS effector, PipB2 (124). Hence, the Sif phenotype appears to be common to both nonphagocytic and phagocytic cells.
Sifs are associated with serovar Typhimurium undergoing rapid intracellular replication (8). Sif formation occurs in a SPI-2-dependent manner and requires the SPI-2 sifA gene (200). Deletion of sifA renders serovar Typhimurium incapable of Sif formation and destabilizes the SCV, leading to bacterial release into the cytosol (5, 200). Hence, Sifs may play a role in maintaining the integrity of the SCV, perhaps by providing a thoroughfare along which late-endosomal membrane materials can be recruited to maintain the bacterial vacuole. Expression of SifA-GFP alone in uninfected cells is sufficient to induce the filamentation and vacuolation of host cell structures containing LAMP-1 (Fig. 8) (13, 24). This suggests SifA may be responsible for directing extensive fusion of late-endocytic compartments with the SCV to promote filamentous Sif formation (105). The SCV remains stable around sifA mutants that lack the sseJ effector gene. SseJ is predicted to have acyltransferase/lipase activity and may be involved in modifying and/or remodeling the SCV in conjunction with SifA (186).
The importance of an intact SCV is apparent by observing the fate of bacteria released into the host cell cytosol upon SCV destabilization. In macrophages or dendritic cells, cytosolic serovar Typhimurium do not replicate and, at least in macrophages, are killed instead (6, 178, 200). In stark contrast, cytosolic bacteria replicate rapidly in epithelial cells (Movie 2) (6, 27). It has recently been observed that cytosolic serovar Typhimurium becomes ubiquitinated upon entry into the cytosol of several cell types, including macrophages and nonphagocytic cells (Fig. 9). Proteasomes were also observed to localize on the surface of cytosolic serovar Typhimurium in macrophages but not in epithelial cells (177). Pharmacologic proteasome inhibition enhanced bacterial replication in macrophages; however, this treatment also appeared to destabilize the SCV and, hence, the role of the proteasome in restricting bacterial growth in the cytosol is unclear (177). Proteasome targeting to serovar Typhimurium in the cytosol of macrophages may play a role in presentation of bacterial peptides on major histocompatibility complex class I (MHC Class I) molecules, an event required for immunity to these bacteria (138, 219). Because macrophages are the host cell niche for serovar Typhimurium during systemic disease, it seems crucial that the integrity of the SCV be maintained to avoid the bactericidal environment of the macrophage cytosol.
In addition to SifA, other effectors, including PipB, PipB2, SifB, SopD2, SseF, SseG, and SseJ (Table 1), have been shown to localize to Sifs and/or SCVs and may modulate their biogenesis (21, 61, 101, 123, 124, 128, 186, 188). Similar to SifA, at least three of these effectors, SseF, SseG, and SopD2, appear to have direct roles in promoting Sif formation (87, 114, 128). For example, deletion of sseF or sseG was shown to arrest Sif formation in serovar Typhimurium-infected cells at an apparently intermediate stage, characterized by the discontinuous localization of LAMP-1 along tubules termed "pseudo-Sifs" (128). Recently, SopD2 was shown to act with SifA to promote the extension of Sifs from the SCV (114). Similar to sseF and sseG deletions, deletion of sopD2 in serovar Typhimurium also disrupted Sif formation, concomitant with an increase in the number of pseudo-Sifs (Fig. 10) (114).
In contrast to these proteins, the SPI-2 effector SseJ and virulence plasmid-encoded SpvB may have roles in negatively regulating Sif formation. Serovar Typhimurium mutants lacking one or both of these genes can induce the formation of significantly more Sifs in epithelial cells (8). However, both proteins are not required for the decline in Sifs typically observed in serovar Typhimurium-infected epithelial cells after 8 to 10 h following invasion (8). Why Sif prevalence decreases at later time points after infection is not clear; however, the involvement of several positive and negative regulatory effectors in the Sif phenotype suggests Sif dynamics are an important aspect of serovar Typhimurium pathogenesis.
Significant amounts of cholesterol are redistributed to the SCV, with as much as 20 to 40% of total cellular cholesterol eventually accumulating on these vacuoles (26, 34). Cholesterol recruitment to the SCV at early and later time points after infection depends on SPI-1 and SPI-2, respectively (34, 77). In addition to cholesterol, glycosylphosphatidylinositol (GPI)-anchored CD55 and glycosphingolipid GM1 are also found on SCVs (34). Cholesterol distribution on the SCV is uneven and "patchy" (26, 34), suggesting that lipid microdomains may form on this vacuole to promote signaling and/or recruiting events that promote SCV maturation (34). Consistent with this, the SPI-2 effectors PipB and PipB2 have been detected in lipid rafts isolated from infected cells, suggesting serovar Typhimurium may exploit such domains to modulate various host activities, such as signal transduction, cytoskeletal remodeling, and membrane and protein trafficking (123, 124).
Modulation of host phosphoinositide metabolism also appears to be essential for serovar Typhimurium growth in host cells (53). While the inositol phosphatase SigD is implicated in facilitating serovar Typhimurium entry (see above) (208), this SPI-1 effector also acts to maintain high levels of PtdIns(3)P on the SCV membrane after bacterial entry (101). In the absence of sopB (gene encoding SigD), serovar Typhimurium exhibited decreased intracellular growth and delayed SCV maturation, suggesting PtdIns(3)P is required to establish a permissive environment for growth in the SCV (101). Elevated levels of PtdIns(3)P on the SCV may contribute to the fusion of the SCV with other bacteria-free, PtdIns(3)P-containing vesicles observed to form near the site of invasion, thus forming more spacious vesicles in which the bacteria reside (101).
Extensive evidence shows that the SCV is derived from the plasma membrane and subsequently interacts selectively with specific components of the endocytic pathway (20, 105, 151, 199). However, recent studies provide some evidence that the SCV, as well as phagosomes in general, may form from the fusion of the endoplasmic reticulum (ER) with the plasma membrane to facilitate particle engulfment (66). By using immunoelectron microscopy, ER-specific glucose-6-phosphatase has been detected on vacuoles surrounding serovar Typhimurium (66). Furthermore, contacts between the ER and SCV have been observed (66). Other proteins associated with the secretory pathway, such as calnexin, calreticulin, and Sec61, have also been detected by using Western blotting on isolated phagosomes formed from internalized latex beads, suggesting this is a general paradigm for phagocytosis (66). As it is established that numerous endocytic markers characterize maturation of the SCV, the contribution of the ER and secretory pathway toward SCV formation will be an interesting topic for further study.
The late SCV is also directed to and surrounded by the Golgi network in a process that depends on the SPI-2 effector SseG (Movie 3) (188). Serovar Typhimurium sseG mutants that are not targeted to the Golgi apparatus are inhibited in intracellular growth (188). The association of SCVs with the Golgi was observed only in epithelial cell lines such as HeLa and INT 407 and not in macrophages; however, it remains possible that SCV–Golgi interactions still occur in phagocytic cells, albeit in a less obvious manner (188). The exploitation of both endocytic and secretory pathways during Salmonella pathogenesis has led to the proposal that the former provides a source of membrane to maintain the SCV, while the latter may provide a source of nutrition for the bacteria (188).
In addition to cell-surface-associated actin rearrangements that facilitate serovar Typhimurium invasion, modulation of actin dynamics along endocytic networks is also important for intracellular bacterial survival. Several hours (4 to 8 h) after invasion, a network of filamentous actin is induced to form de novo around the SCV in a SPI-2 TTSS-dependent process (152). Treatment with actin-depolymerizing agents such as latrunculin B or cytochalasin D destabilized the SCV and significantly decreased intracellular replication of wild-type serovar Typhimurium in RAW and murine-elicited peritoneal macrophages, highlighting the importance of vacuole-associated actin polymerization (VAP) in pathogenesis (152). It is possible that VAP provides a spatial and temporal barrier from host factors that are detrimental to Salmonella replication. Surrounding actin networks may also provide a route along which selective host factors are delivered to the SCV. Currently, it is not known what factor(s) trigger the accumulation of actin around the SCV. The remodeling of actin by internalized serovar Typhimurium does not depend on Rho family GTPases, nor the Arp2/3 complex, in stark contrast to invading bacteria at the host cell surface, suggesting a novel mechanism for inducing actin polymerization in vivo (214).
Recently, the SPI-2 effectors SspH2 and SseI were observed to colocalize with polymerized actin networks surrounding the SCV on transfection. These effectors were shown to interact with the actin-binding proteins filamin (SspH2) and profilin (SspH2 and SseI), suggesting their potential roles in the VAP phenotype; however, VAP could still occur in cells infected with serovar Typhimurium sspH2 and/or sseI mutants (154). VAP structures are not detected at later time points (18 h) after infection (18). In vitro, SspH2 can inhibit actin polymerization; thus, it has been proposed that SspH2 may actually inhibit actin polymerization at a later time after infection, acting with the virulence plasmid-encoded ADP-ribosylating factor SpvB ( 134, 209) to limit VAP formation (123).
Serovar Typhimurium can also modulate microtubule assembly. The SPI-2 effectors SseF and SseG colocalize with and induce the bundling of the host cell microtubule network (129). Furthermore, these effectors appear to aggregate endosomal vesicles along microtubules; hence, it is possible that manipulation of the microtubule network provides internalized bacteria with access to membrane compartments that help maintain the SCV, or that redirect innate host cell antimicrobial factors away from bacteria (129).
Microtubules also play a role in the Sif phenotype. Sifs colocalize with microtubules, and the addition of the microtubule-disrupting drug nocodazole blocks Sif formation (Fig. 11) (18). This indicates that microtubules act as a scaffold on which Sifs are assembled (18, 75). While Sifs also colocalize with actin filaments, disruption of the actin network with cytochalasin D does not prevent their formation (18, 152).
Microtubule motors have recently been implicated in SCV and Sif maturation. During its development, the SCV gradually moves centripetally toward the microtubule-organizing center of the host cell, while Sifs elongate from the SCV in a centrifugal manner. A meshwork of microtubules and the microtubule-associated motors dynein and kinesin localize to the SCV (Fig. 12) (85, 91, 144). The Rab7-interacting lysosomal protein (RILP) is also recruited to the early SCV in a Rab7-dependent manner (85, 91, 144). RILP is involved in coupling Rab7-containing compartments to the dynein/dynactin complex responsible for centripetal migration of intracellular cargo (33, 117). In contrast to the SCV, Sifs that extend from this compartment contain significantly reduced RILP and dynein, despite the presence of active Rab7 on these filamentous structures (Fig. 13) (91). The serovar Typhimurium effector SifA, an important contributor to Sif formation, was shown to interact with Rab7, leading to the proposal that SifA facilitates the centrifugal expansion of Sifs by uncoupling Sif-associated Rab7 from RILP. The resulting RILP-free Sifs would be detached from the centripetal dynein motor complex and would be free to expand outward. Sif elongation also requires centrifugal kinesin motors, which facilitate movement toward the cell periphery (91).
To promote survival in its intracellular niche, serovar Typhimurium has developed mechanisms to evade bactericidal reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI) generated by the host cell (35, 71, 218). Both immunofluorescence and electron microscopy have shown that NADPH oxidase activity, as well as the NADPH oxidase subunits p22phox, p47phox, and cytochrome b558, are significantly reduced on the SCV of wild-type serovar Typhimurium compared with vacuoles containing SPI-2 mutants (Fig. 14) (71, 218). Similarly, inducible nitric oxide synthase (iNOS) does not localize to the SCV of wild-type bacteria (35). Since serovar Typhimurium SPI-2 mutants are unable to avoid the delivery of ROS and RNI to their vacuoles, it suggests that SPI-2-dependent effectors modify the intracellular trafficking of host bactericidal components (35, 71, 218). This involvement of SPI-2 is further highlighted by the fact that SPI-2 mutant bacteria regain their virulence in mice that lack NADPH oxidase activity (218). Currently, it is not known which secreted SPI-2 effector(s) are involved in subverting ROS or RNI delivery to the SCV.
Another host factor implicated in controlling bacterial infection is the natural resistance-associated macrophage protein 1 (Nramp1), also known as solute carrier 11a1 (SLC11A1), a divalent metal transporter associated with lysosomal compartments in macrophages (84, 220). Nramp1+/+ mice are resistant to serovar Typhimurium infection; however, the mechanism for this is not clear (220). Nramp1 may confer resistance to serovar Typhimurium by actively depleting the SCV of Fe2+, Mn2+, or other essential divalent cations, or by promoting SCV fusion with the normal endocytic pathway (46, 109, 110, 232). Note that serovar Typhimurium still exhibit SPI-2 dependent replication in Nramp1+/+ mice, albeit not to the high levels observed in susceptible Nramp1–/–animals . In fact, serovar Typhimurium can persist within mesenteric lymph node macrophages of Nramp1+/+ mice for at least a year (161). This ability to chronically infect a host may, in part, be the result of upregulated SPI-2-associated gene expression in the presence of Nramp1 (232). Because the SPI-2 TTSS, or its translocated effectors, is required for replication in Nramp1+/+ mice, it is conceivable that SPI-2 acts to counter the detrimental effects of Nramp1 and promote persistent infection (232).
In addition to affecting host cytoskeletal rearrangements and endocytic trafficking, serovar Typhimurium can modulate host gene expression, particularly those involved in cytokine production. Infection of cultured intestinal epithelial cells has been shown to activate ERK, c-Jun NH2-terminal kinases (JNK), and p38 protein kinase pathways (36, 89, 104, 174, 184). These pathways can activate NF-κB, an important transcriptional factor of proinflammatory cytokines such as interleukin-8 (IL-8) (104). The interaction of serovar Typhimurium with polarized epithelial cells induces the basolateral secretion of IL-8 (55, 146). Serovar Typhimurium attachment to these polarized cells also stimulates the release of other chemoattractants on the apical surface (146, 147, 148). As a result, transepithelial polymorphonuclear neutrophil (PMN) migration proceeds toward the apical membrane.
While this localized inflammatory response induced by serovar Typhimurium may facilitate its ability to invade and spread within the host (163), the influx of immune cells to sites of inflammation may be detrimental to the pathogenic cycle as well. As such, several serovar Typhimurium effectors, namely AvrA and SptP (secreted by SPI-1) and SspH1(secreted by both SPI-1 and SPI-2 TTSS) (Table 1), appear to have roles in downmodulating IL-8 production after invasion (43, 88). AvrA inhibits the NF-κB signaling pathway by blocking the pathway downstream of IKK activation and preventing the p65 subunit of NF-κB from entering into the nucleus (43). SspH1 appears to act by localizing to the host cell nucleus after its translocation where it presumably inhibits NF-κB-dependent gene expression (88). SptP, normally involved in reversing actin polymerizations at the host cell surface, can also attenuate IL-8 production (88). However, SptP has been localized to the plasma membrane by using both immunofluorescence and cell fractionation studies (32), suggesting that this effector disrupts IL-8 gene expression by affecting signaling events at the host cell surface.
The presentation of peptides by MHC class I and class II molecules forms an integral part of the host T-cell immune response. To counter this, intracellular bacteria have developed several strategies to modulate or impair antigen presentation. These strategies include inhibiting the maturation of phagosomal compartments to limit bacterial degradation and impairing synthesis of MHC class I and II molecules (139). Studies have shown that expression of serovar Typhimurium phoP-regulated genes can impair the processing and MHC class II presentation of antigens expressed by the bacteria (225). In the absence of phoP, serovar Typhimurium are more efficiently presented by MHC class II molecules (225). Currently it is not known which of the phoP-regulated genes in serovar Typhimurium are involved in modulating antigen presentation by host cells.
Serovar Typhimurium can also downregulate the translocation of MHC class II molecules to the host cell surface (159). This process does not affect overall class II biosynthesis and peptide loading and, as a result, class II molecules accumulate within the host cell in LAMP-1-positive vacuoles that are distinct from the SCV. SifA may have a role in this process, since mutant sifA bacteria do not inhibit cell surface presentation of MHC class II molecules (159).
A serovar Typhimurium gene involved in disrupting peptide presentation by MHC class I molecules has also been identified. Inactivation of this gene, yej, was shown to increase MHC class I presentation in murine macrophages and to induce CD8+ T-cell responses against serovar Typhimurium in mouse models (180). Hence, serovar Typhimurium has developed several ways to avoid eliciting CD4+ and CD8+ T-cell responses by restricting the presentation of Salmonella-derived epitopes. While the exact mechanisms of restricting class I and class II presentation are not known, they will undoubtedly provide interesting avenues of future study.
During the systemic phase of disease, serovar Typhimurium relies primarily on phagocytic cells such as macrophages and dendritic cells to provide replicative niches and/or vehicles for dissemination (183, 189, 224). While essential for systemic infection, macrophages also undergo a cell death process triggered by serovar Typhimurium infection. Both SPI-1 and SPI-2 TTSSs are able to induce this event at different times by using different mechanisms in vitro (107). SPI-1-mediated cell death does not require bacterial internalization, provided the SPI-1 TTSS genes are expressed optimally (37).
The exact nature of Salmonella-induced cytotoxicity has been the subject of considerable discussion (11, 107, 121). Macrophages undergoing Salmonella-induced death exhibit features that are typical of both apoptosis and necrosis. Classical apoptotic changes, including chromatin condensation and fragmentation, cytoplasmic vacuolation, and membrane blebbing have been observed in infected macrophages (Fig. 15) (37, 165). Others have observed dying macrophage morphologies more consistent with necrosis, including disrupted nuclear and plasma membranes and a lack of DNA condensation or fragmentation (17, 223). These distinctly different observations may be a reflection of the increasingly blurred lines of distinction between apoptosis and necrosis (121). Furthermore, these differences may have resulted from the different experimental conditions used in each study (121).
What is apparent is that caspase-1, belonging to a class of caspases implicated in inflammatory responses, is involved in Salmonella-induced cell death. Loss of caspase-1 activity confers increased macrophage resistance to serovar Typhimurium-induced cytotoxicity (17, 102, 103). Furthermore, caspase-1-knockout mice have significantly greater resistance against serovar Typhimurium than wild-type mice do (163). The SPI-1 translocon component/effector SipB has been shown to bind and activate caspase-1, resulting in the processing and release of IL-1β and IL-18 accompanying macrophage cell death (103, 170). Dendritic cells also exhibit Salmonella-induced cell death that depends on bacterial SipB and host cell caspase-1 (216). In addition, the cytotoxic effects of serovar Typhimurium depend on the activation of Cdc42 and Rac-1, which are normally stimulated upon bacterial invasion (see above); however, the mechanism(s) by which these Rho-GTPases induce/signal host cell death is not clear (60).
While IL-1β and IL-18 are not required for the actual process of cell death itself (164), the caspase-1-mediated release of these cytokines may have a proinflammatory role that supports the spread of serovar Typhimurium within the host. One interesting proposal is that IL-1β and IL-18 contribute to inflammation and disruption of the intestinal barrier to facilitate secondary bacterial invasion (112, 121). It has also been proposed that sites of Salmonella-induced inflammation and cell death could attract other phagocytic cells, including dendritic cells, which may be used by serovar Typhimurium to further disseminate within the host (112). The antigenic material released from macrophages that succumb to Salmonella-induced cell death can be processed and presented by bystander dendritic cells (230). Hence, it is possible that the host cell immune system can benefit from the death of macrophages by virtue of released Salmonella antigens that can be more efficiently presented to T cells by dendritic cells (204, 230).
Despite the importance of caspase-1 in mediating rapid macrophage death, even caspase-1-deficient macrophages eventually succumb to serovar Typhimurium infection (102, 113). This death pathway also requires SipB; however, caspase-2 activation is also involved ( 113). In addition, caspase-1-deficient macrophages may succumb to autophagy-mediated, or type II, cell death upon serovar Typhimurium infection. Again, SipB is involved in this process, which has been observed to localize to mitochondria where it appears to disrupt organelle integrity (102). Furthermore, SipB can induce the formation of and localize within multilamellar structures that resemble autophagosomes surrounding, or in close association with, mitochondria in transfected epithelial cells (Fig. 16). Because caspase-1-deficient macrophages still succumb to Salmonella-induced death in the presence of a pan-caspase inhibitor, it appears that autophagy itself is the main contributor to cytotoxicity in these cells (102).
Activation of caspase-3 is well characterized to initiate the classic apoptotic pathway; however, it has been reported that Salmonella-induced cell death is caspase-3 independent (17). Recently, SPI-1 proteins were found to be continuously expressed in a serovar Typhimurium ▵Lon strain residing in macrophages, resulting in increased caspase-3-mediated apoptosis compared with the wild-type control (205). Hence, Lon protease may play a role in suppressing the induction of the caspase-3 cascade by serovar Typhimurium, thus preventing excessive macrophage apoptosis that might otherwise elicit a heightened host immune response, in particular, through bystander dendritic cells (205).
Serovar Typhimurium can also kill macrophages in the absence of an active SPI-1 TTSS. However, this killing is delayed, beginning up to 12 h after infection, and occurs in a SPI-2-dependent manner (162, 215). Although the effector(s) that may be involved are currently not known, SPI-2-dependent cytotoxicity is mediated in part by caspase-1 (162, 215). SPI-2-mediated cell death also results in the release of IL-1β, which may induce inflammation and promote dissemination of the pathogen at systemic sites of infection such as the liver and spleen (162).
Other mechanisms for inducing cell death have also been described for serovar Typhimurium. Sequence analysis of another Salmonella pathogenicity island, SPI-4, indicates it may encode a type I (ATP-binding cassette) secretion system (227). Such systems are often associated with the export of cytotoxins (7). Because several cytotoxins are encoded by various Salmonella species (135, 140, 187), it is possible that their secretion is mediated by SPI-4; however, studies must be done to confirm this. Microarray analysis of human macrophage gene responses to invading wild-type and phoP-deficient serovar Typhimurium have also revealed a role for the bacterial phoP/phoQ regulatory system in promoting host cell death (51). Again, little is known about which serovar Typhimurium phoP/phoQ -regulated gene(s) may be involved in cytotoxicity. Finally, expression of the Salmonella ADP-ribosylating protein SpvB is also able to induce apoptosis in macrophages (131); however, there is no evidence that SpvB is secreted by a TTSS. Thus, it is apparent that serovar Typhimurium can trigger host cell death by multiple routes. The benefits that arise from host cell killing, however, remain to be determined.
It is now clearly established that serovar Typhimurium invasion and intracellular parasitism involves an intricate series of spatially and temporally regulated events. This demands that serovar Typhimurium be able to engage specific host cell machinery during every point of the infection cycle, from initial contact with the host cell to replication within the SCV. This continuous interaction with the host cell has likely contributed to the extensive arsenal that serovar Typhimurium now possesses, including two type III secretion systems, a range of ammunition in the form of TTSS effectors, and a complex genetic regulatory network that coordinates the expression of hundreds of virulence factors.
Studies of serovar Typhimurium intracellular parasitism have provided valuable insight into the inner workings and failures of the host cell in dealing with a highly successful pathogen. Not surprisingly, these same studies have spawned many more questions than answers regarding Salmonella-induced modulation of host cell systems. Despite identifying many secreted Salmonella proteins and noting their localization and the phenotypes they induce, we are only beginning to elucidate the molecular mechanisms of action for a select few TTSS effectors. Much research has centered around SifA, the effector protein essential for Sif formation, which provides SCV stability and determines the fate of internalized serovar Typhimurium. While current proposals favor that Sifs are involved in recruiting host membrane compartments for maintenance of the SCV, the actual function of the Sif structures themselves is still unclear.
Thus far, the maturation of the SCV has also been perplexing. This compartment selectively acquires only a subset of late-endosomal markers. The origins of these markers in the endocytic pathway is not known but may reflect the existence of intermediate fusogenic steps, in particular, in later stages of endosome maturation. Identification of the complete proteome of the SCV would be especially useful; however, technical challenges have limited the success of this endeavor to date (158).
Several reports have also implicated the importance of the phoP/phoQ regulatory system in serovar Typhimurium pathogenesis. Since this two-component system regulates several dozen serovar Typhimurium genes, the identification of specific phoP/phoQ-regulated genes implicated in promoting host colonization by this pathogen would provide a much clearer picture of how these bacteria usurp the host cell. The identification by microarray analyses of several hundred serovar Typhimurium genes upregulated within the macrophage has also provided many candidate pathogenesis genes of which little, or nothing, is known.
Questions abound regarding how serovar Typhimurium deals with host immune defenses. How do the bacteria avoid ROS and RNI? What allows the bacteria to modulate MHC class I and II presentation? Does Salmonella-induced macrophage cell death benefit the pathogen or the host? These and many other important questions await investigation in our attempts to unravel the mechanisms responsible for successful intracellular pathogenesis by serovar Typhimurium and other Salmonella serovars. Ultimately, it is pertinent to confirm the observations made during in vitro cell culture experiments in animal disease models. In doing so, it will be possible to determine which of the many Salmonella-induced phenotypes in host cells are truly relevant in promoting disease.
Our work is supported by grant funding and a New Investigator Award from the Canadian Institutes of Health Research (to J.H.B.). Infrastructure for the Brumell laboratory was provided by a New Opportunities Fund from the Canadian Foundation for Innovation and the Ontario Innovation Trust. J.H.B. is a recipient of the Premier’s Research Excellence Award from the Ontario Ministry of Economic Development and Trade. J.S. is supported by a CAG/CIHR/Solvay Pharma postdoctoral fellowship administered by the Canadian Association of Gastroenterology.
We thank Dr. B. Brett Finlay and members of the Brumell laboratory for critically reading the manuscript.
References
1. Alpuche-Aranda, C. M., E. L. Racoosin, J. A. Swanson, and S. I. Miller. 1994. Salmonella stimulate macrophage macropinocytosis and persist within spacious phagosomes. J. Exp. Med. 179:601–608.[PubMed] [CrossRef]
2. Bajaj, V., R. L. Lucas, C. Hwang, and C. A. Lee. 1996. Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol. Microbiol. 22:703–714.[PubMed] [CrossRef]
3. Bakshi, C. S., V. P. Singh, M. W. Wood, P. W. Jones, T. S. Wallis, and E. E. Galyov. 2000. Identification of SopE2, a Salmonella secreted protein which is highly homologous to SopE and involved in bacterial invasion of epithelial cells. J. Bacteriol. 182:2341–2344.[PubMed] [CrossRef]
4. Bertelsen, L. S., G. Paesold, S. L. Marcus, B. B. Finlay, L. Eckmann, and K. E. Barrett. 2004. Modulation of chloride secretory responses and barrier function of intestinal epithelial cells by the Salmonella effector protein SigD. Am. J. Physiol. 287:C939–C948. [CrossRef]
5. Beuzon, C. R., S. Meresse, K. E. Unsworth, J. Ruiz-Albert, S. Garvis, S. R. Waterman, T. A. Ryder, E. Boucrot, and D. W. Holden. 2000. Salmonella maintains the integrity of its intracellular vacuole through the action of SifA. EMBO J. 19:3235–3249.[PubMed] [CrossRef]
6. Beuzon, C. R., S. P. Salcedo, and D. W. Holden. 2002. Growth and killing of a Salmonella enterica serovar Typhimurium sifA mutant strain in the cytosol of different host cell lines. Microbiology 148:2705–2715.[PubMed]
7. Binet, R., S. Letoffe, J. M. Ghigo, P. Delepelaire, and C. Wandersman. 1997. Protein secretion by gram-negative bacterial ABC exporters. Folia Microbiol. (Praha) 42:179–183.[PubMed] [CrossRef]
8. Birmingham, C. L., X. Jiang, M. B. Ohlson, S. I. Miller, and J. H. Brumell. 2005. Salmonella-induced filament formation is a dynamic phenotype induced by rapidly replicating Salmonella enterica serovar Typhimurium in epithelial cells. Infect. Immun. 73:1204-1208. [CrossRef]
9. Birtalan, S. C., R. M. Phillips, and P. Ghosh. 2002. Three-dimensional secretion signals in chaperone-effector complexes of bacterial pathogens. Mol. Cell 9:971–980.[PubMed] [CrossRef]
10. Blanc-Potard, A. B., and E. A. Groisman. 1997. The Salmonella selC locus contains a pathogenicity island mediating intramacrophage survival. EMBO J. 16:5376–5385.[PubMed] [CrossRef]
11. Boise, L. H., and C. M. Collins. 2001. Salmonella-induced cell death: apoptosis, necrosis or programmed cell death? Trends Microbiol. 9:64–67.[PubMed] [CrossRef]
12. Botelho, R. J., M. Teruel, R. Dierckman, R. Anderson, A. Wells, J. D. York, T. Meyer, and S. Grinstein. 2000. Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J. Cell Biol. 151:1353–1368.[PubMed] [CrossRef]
13. Boucrot, E., C. R. Beuzon, D. W. Holden, J. P. Gorvel, and S. Meresse. 2003. Salmonella typhimurium SifA effector protein requires its membrane-anchoring C-terminal hexapeptide for its biological function. J. Biol. Chem. 278:14196–14202.[PubMed] [CrossRef]
14. Bowe, F., C. J. Lipps, R. M. Tsolis, E. Groisman, F. Heffron, and J. G. Kusters. 1998. At least four percent of the Salmonella typhimurium genome is required for fatal infection of mice. Infect. Immun. 66:3372–3377.[PubMed]
15. Boyd, E. F., and H. Brussow. 2002. Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved. Trends Microbiol. 10:521–529.[PubMed] [CrossRef]
16. Brandt, S. M., M. S. Dionne, R. S. Khush, L. N. Pham, T. J. Vigdal, and D. S. Schneider. 2004. Secreted bacterial effectors and host-produced eiger/TNF drive death in a salmonella-infected fruit fly. PLoS Biol. 2:e418. [CrossRef]
17. Brennan, M. A., and B. T. Cookson. 2000. Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol. Microbiol. 38:31–40.[PubMed] [CrossRef]
18. Brumell, J. H., D. L. Goosney, and B. B. Finlay. 2002. SifA, a type III secreted effector of Salmonella Typhimurium, directs Salmonella-induced filament (Sif) formation along microtubules. Traffic 3:407–415.[PubMed] [CrossRef]
19. Brumell, J. H., and S. Grinstein. 2003. Role of lipid-mediated signal transduction in bacterial internalization. Cell. Microbiol. 5:287–297.[PubMed] [CrossRef]
20. Brumell, J. H., and S. Grinstein. 2004. Salmonella redirects phagosomal maturation. Curr. Opin. Microbiol. 7:78–84.[PubMed] [CrossRef]
21. Brumell, J. H., S. Kujat-Choy, N. F. Brown, B. A. Vallance, L. A. Knodler, and B. B. Finlay. 2003. SopD2 is a novel type III secreted effector of Salmonella typhimurium that targets late endocytic compartments upon delivery into host cells. Traffic 4:36–48.[PubMed] [CrossRef]
22. Brumell, J. H., S. L. Marcus, and B. B. Finlay. 2000. N-terminal conservation of putative type III secreted effectors of Salmonella typhimurium. Mol. Microbiol. 36:773–774.[PubMed] [CrossRef]
23. Brumell, J. H., A. J. Perrin, D. L. Goosney, and B. B. Finlay. 2002. Microbial pathogenesis: new niches for Salmonella. Curr. Biol. 12:R15–R17.[PubMed] [CrossRef]
24. Brumell, J. H., C. M. Rosenberger, G. T. Gotto, S. L. Marcus, and B. B. Finlay. 2001. SifA permits survival and replication of Salmonella typhimurium in murine macrophages. Cell. Microbiol. 3:75–84.[PubMed] [CrossRef]
25. Brumell, J. H., O. Steele-Mortimer, and B. B. Finlay. 1999. Bacterial invasion: force feeding by Salmonella. Curr. Biol. 9:R277–R280.[PubMed] [CrossRef]
26. Brumell, J. H., P. Tang, S. D. Mills, and B. B. Finlay. 2001. Characterization of Salmonella-induced filaments (Sifs) reveals a delayed interaction between salmonella-containing vacuoles and late endocytic compartments. Traffic 2:643–653.[PubMed] [CrossRef]
27. Brumell, J. H., P. Tang, M. L. Zaharik, and B. B. Finlay. 2002. Disruption of the Salmonella-containing vacuole leads to increased replication of Salmonella enterica serovar typhimurium in the cytosol of epithelial cells. Infect. Immun. 70:3264–3270.[PubMed] [CrossRef]
28. Buchmeier, N. A., and F. Heffron. 1991. Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium. Infect. Immun. 59:2232–2238.[PubMed]
29. Buchmeier, N. A., and S. J. Libby. 1997. Dynamics of growth and death within a Salmonella typhimurium population during infection of macrophages. Can. J. Microbiol. 43:29–34.[PubMed]
30. Buchwald, G., A. Friebel, J. E. Galan, W. D. Hardt, A. Wittinghofer, and K. Scheffzek. 2002. Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J. 21:3286–3295.[PubMed] [CrossRef]
31. Buttner, D., and U. Bonas. 2002. Port of entry—the type III secretion translocon. Trends Microbiol. 10:186–192.[PubMed] [CrossRef]
32. Cain, R. J., R. D. Hayward, and V. Koronakis. 2004. The target cell plasma membrane is a critical interface for Salmonella cell entry effector-host interplay. Mol. Microbiol. 54:887–904.[PubMed] [CrossRef]
33. Cantalupo, G., P. Alifano, V. Roberti, C. B. Bruni, and C. Bucci. 2001. Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes. EMBO J. 20:683–693.[PubMed] [CrossRef]
34. Catron, D. M., M. D. Sylvester, Y. Lange, M. Kadekoppala, B. D. Jones, D. M. Monack, S. Falkow, and K. Haldar. 2002. The Salmonella-containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI-anchored protein CD55. Cell. Microbiol. 4:315–328.[PubMed] [CrossRef]
35. Chakravortty, D., I. Hansen-Wester, and M. Hensel. 2002. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J. Exp. Med. 195:1155–1166.[PubMed] [CrossRef]
36. Chen, L. M., S. Hobbie, and J. E. Galan. 1996. Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses. Science 274:2115–2118.[PubMed] [CrossRef]
37. Chen, L. M., K. Kaniga, and J. E. Galan. 1996. Salmonella spp. are cytotoxic for cultured macrophages. Mol. Microbiol. 21:1101–1115.[PubMed] [CrossRef]
38. Cheng, L. W., and O. Schneewind. 2000. Type III machines of Gram-negative bacteria: delivering the goods. Trends Microbiol. 8:214–220.[PubMed] [CrossRef]
39. Cirillo, D. M., R. H. Valdivia, D. M. Monack, and S. Falkow. 1998. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol. Microbiol. 30:175–188.[PubMed] [CrossRef]
40. Collazo, C. M., and J. E. Galan. 1997. The invasion-associated type III system of Salmonella typhimurium directs the translocation of Sip proteins into the host cell. Mol. Microbiol. 24:747–756.[PubMed] [CrossRef]
41. Collazo, C. M., and J. E. Galan. 1996. Requirement for exported proteins in secretion through the invasion- associated type III system of Salmonella typhimurium. Infect. Immun. 64:3524–3531.[PubMed]
42. Collazo, C. M., M. K. Zierler, and J. E. Galan. 1995. Functional analysis of the Salmonella typhimurium invasion genes invl and invJ and identification of a target of the protein secretion apparatus encoded in the inv locus. Mol. Microbiol. 15:25–38.[PubMed] [CrossRef]
43. Collier-Hyams, L. S., H. Zeng, J. Sun, A. D. Tomlinson, Z. Q. Bao, H. Chen, J. L. Madara, K. Orth, and A. S. Neish. 2002. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J. Immunol. 169:2846–2850.[PubMed]
43a. Coombes, B. K., M. E. Wickham, N. F. Brown, S. Lemire, L. Bossi, W. W. Hsiao, F. S. Brinkman, and B. B. Finlay. 2005. Genetic and molecular analysis of GogB, a phage-encoded type III-secreted substrate in Salmonella enterica serovar typhimurium with autonomous expression from its associated phage. J. Mol. Biol. 348:817–830.[PubMed] [CrossRef]
44. Cornelis, G. R., and F. Van Gijsegem. 2000. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 54:735–774.[PubMed] [CrossRef]
45. Criss, A. K., D. M. Ahlgren, T. S. Jou, B. A. McCormick, and J. E. Casanova. 2001. The GTPase Rac1 selectively regulates Salmonella invasion at the apical plasma membrane of polarized epithelial cells. J. Cell Sci. 114:1331–1341.[PubMed]
46. Cuellar-Mata, P., N. Jabado, J. Liu, W. Furuya, B. B. Finlay, P. Gros, and S. Grinstein. 2002. Nramp1 modifies the fusion of Salmonella typhimurium-containing vacuoles with cellular endomembranes in macrophages. J. Biol. Chem. 277:2258–2265.[PubMed] [CrossRef]
47. Darwin, K. H., and V. L. Miller. 2000. The putative invasion protein chaperone SicA acts together with InvF to activate the expression of Salmonella typhimurium virulence genes. Mol. Microbiol. 35:949–960.[PubMed] [CrossRef]
48. Darwin, K. H., and V. L. Miller. 2001. Type III secretion chaperone-dependent regulation: activation of virulence genes by SicA and InvF in Salmonella typhimurium. EMBO J. 20:1850–1862.[PubMed] [CrossRef]
49. Deiwick, J., T. Nikolaus, S. Erdogan, and M. Hensel. 1999. Environmental regulation of Salmonella pathogenicity island 2 gene expression. Mol. Microbiol. 31:1759–1773.[PubMed] [CrossRef]
50. Deiwick, J., T. Nikolaus, J. E. Shea, C. Gleeson, D. W. Holden, and M. Hensel. 1998. Mutations in Salmonella pathogenicity island 2 (SPI2) genes affecting transcription of SPI1 genes and resistance to antimicrobial agents. J. Bacteriol. 180:4775–4780.[PubMed]
51. Detweiler, C. S., D. B. Cunanan, and S. Falkow. 2001. Host microarray analysis reveals a role for the Salmonella response regulator phoP in human macrophage cell death. Proc. Natl. Acad. Sci. USA 98:5850–5855.[PubMed] [CrossRef]
52. Drecktrah, D., L. A. Knodler, K. Galbraith, and O. Steele-Mortimer. 2005. The Salmonella SPI1 effector SopB stimulates nitric oxide production long after invasion. Cell. Microbiol. 7:105–113.[PubMed] [CrossRef]
53. Drecktrah, D., L. A. Knodler, and O. Steele-Mortimer. 2004. Modulation and utilization of host cell phosphoinositides by Salmonella spp. Infect. Immun. 72:4331–4335.[PubMed] [CrossRef]
54. Dunlap, N. E., W. H. Benjamin, Jr., R. D. McCall, Jr., A. B. Tilden, and D. E. Briles. 1991. A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice. Microb. Pathog. 10:297–310.[PubMed] [CrossRef]
55. Eckmann, L., M. F. Kagnoff, and J. Fierer. 1993. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect. Immun. 61:4569–4574.[PubMed]
56. Eriksson, S., S. Lucchini, A. Thompson, M. Rhen, and J. C. Hinton. 2003. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol. Microbiol. 47:103–118.[PubMed] [CrossRef]
57. Ernst, R. K., T. Guina, and S. I. Miller. 2001. Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microb. Infect. 3:1327–1334. [CrossRef]
58. Feldman, M. F., and G. R. Cornelis. 2003. The multitalented type III chaperones: all you can do with 15 kDa. FEMS Microbiol. Lett. 219:151–158.[PubMed] [CrossRef]
59. Finlay, B. B., and J. H. Brumell. 2000. Salmonella interactions with host cells: in vitro to in vivo. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355:623–631.[PubMed] [CrossRef]
60. Forsberg, M., R. Blomgran, M. Lerm, E. Sarndahl, S. M. Sebti, A. Hamilton, O. Stendahl, and L. Zheng. 2003. Differential effects of invasion by and phagocytosis of Salmonella typhimurium on apoptosis in human macrophages: potential role of Rho-GTPases and Akt. J. Leukoc. Biol. 74:620–629.[PubMed] [CrossRef]
61. Freeman, J. A., M. E. Ohl, and S. I. Miller. 2003. The Salmonella enterica serovar typhimurium translocated effectors SseJ and SifB are targeted to the Salmonella-containing vacuole. Infect. Immun. 71:418–427.[PubMed] [CrossRef]
62. Freeman, J. A., C. Rappl, V. Kuhle, M. Hensel, and S. I. Miller. 2002. SpiC is required for translocation of Salmonella pathogenicity island 2 effectors and secretion of translocon proteins SseB and SseC. J. Bacteriol. 184:4971–4980.[PubMed] [CrossRef]
63. Friebel, A., H. Ilchmann, M. Aepfelbacher, K. Ehrbar, W. Machleidt, and W. D. Hardt. 2001. SopE and SopE2 from Salmonella typhimurium activate different sets of RhoGTPases of the host cell. J. Biol. Chem. 276:34035–34040.[PubMed] [CrossRef]
64. Fu, Y., and J. E. Galan. 1999. A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401:293–297.[PubMed] [CrossRef]
65. Fu, Y., and J. E. Galan. 1998. The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton. Mol. Microbiol. 27:359–368.[PubMed] [CrossRef]
66. Gagnon, E., S. Duclos, C. Rondeau, E. Chevet, P. H. Cameron, O. Steele-Mortimer, J. Paiement, J. J. Bergeron, and M. Desjardins. 2002. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110:119–131.[PubMed] [CrossRef]
67. Galan, J. E. 1999. Interaction of Salmonella with host cells through the centisome 63 type III secretion system. Curr. Opin. Microbiol. 2:46–50.[PubMed] [CrossRef]
68. Galan, J. E. 2001. Salmonella interactions with host cells: type III secretion at work. Annu. Rev. Cell Dev. Biol. 17:53–86.[PubMed] [CrossRef]
69. Galan, J. E., and R. D. Curtiss. 1989. Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc. Natl. Acad. Sci. USA 86:6383–6387.[PubMed] [CrossRef]
70. Galan, J. E., and D. Zhou. 2000. Striking a balance: modulation of the actin cytoskeleton by Salmonella. Proc. Natl. Acad. Sci. USA 97:8754–8761.[PubMed] [CrossRef]
71. Gallois, A., J. R. Klein, L. A. Allen, B. D. Jones, and W. M. Nauseef. 2001. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J. Immunol. 166:5741–5748.[PubMed]
72. Garcia Vescovi, E., F. C. Soncini, and E. A. Groisman. 1994. The role of the PhoP/PhoQ regulon in Salmonella virulence. Res. Microbiol. 145:473–480.[PubMed] [CrossRef]
73. Garcia-del Portillo, F., and B. B. Finlay. 1995. Targeting of Salmonella typhimurium to vesicles containing lysosomal membrane glycoproteins bypasses compartments with mannose 6-phosphate receptors. J. Cell Biol. 129:81–97.[PubMed] [CrossRef]
74. Garcia-del Portillo, F., M. B. Zwick, K. Y. Leung, and B. B. Finlay. 1993. Intracellular replication of Salmonella within epithelial cells is associated with filamentous structures containing lysosomal membrane glycoproteins. Infect. Agents Dis. 2:227–231.[PubMed]
75. Garcia-del Portillo, F., M. B. Zwick, K. Y. Leung, and B. B. Finlay. 1993. Salmonella induces the formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells. Proc. Natl. Acad. Sci. USA 90:10544–10548.[PubMed] [CrossRef]
76. Garmendia, J., C. R. Beuzon, J. Ruiz-Albert, and D. W. Holden. 2003. The roles of SsrA-SsrB and OmpR-EnvZ in the regulation of genes encoding the Salmonella typhimurium SPI-2 type III secretion system. Microbiology 149:2385–2396.[PubMed] [CrossRef]
77. Garner, M. J., R. D. Hayward, and V. Koronakis. 2002. The Salmonella pathogenicity island 1 secretion system directs cellular cholesterol redistribution during mammalian cell entry and intracellular trafficking. Cell. Microbiol. 4:153–165.[PubMed] [CrossRef]
78. Garvis, S. G., C. R. Beuzon, and D. W. Holden. 2001. A role for the PhoP/Q regulon in inhibition of fusion between lysosomes and Salmonella-containing vacuoles in macrophages. Cell. Microbiol. 3:731–744.[PubMed] [CrossRef]
79. Ghosh, P. 2004. Process of protein transport by the type III secretion system. Microbiol. Mol. Biol. Rev. 68:771–795.[PubMed] [CrossRef]
80. Gotoh, H., N. Okada, Y. G. Kim, K. Shiraishi, N. Hirami, T. Haneda, A. Kurita, Y. Kikuchi, and H. Danbara. 2003. Extracellular secretion of the virulence plasmid-encoded ADP-ribosyltransferase SpvB in Salmonella. Microb. Pathog. 34:227–238.[PubMed] [CrossRef]
81. Groisman, E. A. 2001. The pleiotropic two-component regulatory system PhoP-PhoQ. J. Bacteriol. 183:1835–1842.[PubMed] [CrossRef]
82. Groisman, E. A., and H. Ochman. 1993. Cognate gene clusters govern invasion of host epithelial cells by Salmonella typhimurium and Shigella flexneri. EMBO J. 12:3779–3787.[PubMed]
83. Groisman, E. A., and H. Ochman. 1997. How Salmonella became a pathogen. Trends Microbiol. 5:343–349.[PubMed] [CrossRef]
84. Gruenheid, S., E. Pinner, M. Desjardins, and P. Gros. 1997. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J. Exp. Med. 185:717–730.[PubMed] [CrossRef]
85. Guignot, J., E. Caron, C. Beuzon, C. Bucci, J. Kagan, C. Roy, and D. W. Holden. 2004. Microtubule motors control membrane dynamics of Salmonella-containing vacuoles. J. Cell Sci. 117:1033–1045.[PubMed] [CrossRef]
86. Guo, L., K. B. Lim, J. S. Gunn, B. Bainbridge, R. P. Darveau, M. Hackett, and S. I. Miller. 1997. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250–253.[PubMed] [CrossRef]
87. Guy, R. L., L. A. Gonias, and M. A. Stein. 2000. Aggregation of host endosomes by Salmonella requires SPI2 translocation of SseFG and involves SpvR and the fms-aroE intragenic region. Mol. Microbiol. 37:1417–1435.[PubMed] [CrossRef]
88. Haraga, A., and S. I. Miller. 2003. A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. Infect. Immun. 71:4052–4058.[PubMed] [CrossRef]
89. Hardt, W. D., L. M. Chen, K. E. Schuebel, X. R. Bustelo, and J. E. Galan. 1998. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93:815–826.[PubMed] [CrossRef]
90. Harrison, R. E., J. H. Brumell, A. Khandani, C. Bucci, C. C. Scott, X. Jiang, B. B. Finlay, and S. Grinstein. 2004. Salmonella impairs RILP recruitment to Rab7 during maturation of invasion vacuoles. Mol. Biol. Cell. 15:3146–3154.[PubMed] [CrossRef]
91. Harrison, R. E., J. H. Brumell, A. Khandani, C. Bucci, C. C. Scott, X. Jiang, B. B. Finlay, and S. Grinstein. 2004. Salmonella impairs RILP recruitment to Rab7 during maturation of invasion vacuoles. Mol. Biol. Cell 15:3146–3154.[PubMed] [CrossRef]
92. Hashim, S., K. Mukherjee, M. Raje, S. K. Basu, and A. Mukhopadhyay. 2000. Live Salmonella modulate expression of Rab proteins to persist in a specialized compartment and escape transport to lysosomes. J. Biol. Chem. 275:16281–16288.[PubMed] [CrossRef]
93. Hayward, R. D., and V. Koronakis. 1999. Direct nucleation and bundling of actin by the SipC protein of invasive Salmonella. EMBO J. 18:4926–4934.[PubMed] [CrossRef]
94. Hayward, R. D., E. J. McGhie, and V. Koronakis. 2000. Membrane fusion activity of purified SipB, a Salmonella surface protein essential for mammalian cell invasion. Mol. Microbiol. 37:727–739.[PubMed] [CrossRef]
95. Heithoff, D. M., C. P. Conner, P. C. Hanna, S. M. Julio, U. Hentschel, and M. J. Mahan. 1997. Bacterial infection as assessed by in vivo gene expression. Proc. Natl. Acad. Sci. USA 94:934–939.[PubMed] [CrossRef]
96. Hensel, M. 2004. Evolution of pathogenicity islands of Salmonella enterica. Int. J. Med. Microbiol. 294:95–102.[PubMed] [CrossRef]
97. Hensel, M. 2000. Salmonella pathogenicity island 2. Mol. Microbiol. 36:1015–1023.[PubMed] [CrossRef]
98. Hensel, M., J. E. Shea, B. Raupach, D. Monack, S. Falkow, C. Gleeson, T. Kubo, and D. W. Holden. 1997. Functional analysis of ssaJ and the ssaK/U operon, 13 genes encoding components of the type III secretion apparatus of Salmonella Pathogenicity Island 2. Mol. Microbiol. 24:155–167.[PubMed] [CrossRef]
99. Hensel, M., J. E. Shea, S. R. Waterman, R. Mundy, T. Nikolaus, G. Banks, A. Vazquez-Torres, C. Gleeson, F. C. Fang, and D. W. Holden. 1998. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol. Microbiol. 30:163–174.[PubMed] [CrossRef]
100. Hensel, M., J. E. Shea, S. R. Waterman, R. Mundy, T. Nikolaus, G. Banks, A. Vazquez-Torres, C. Gleeson, F. C. Fang, and D. W. Holden. 1998. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol. Microbiol. 30:163–174.[PubMed] [CrossRef]
101. Hernandez, L. D., K. Hueffer, M. R. Wenk, and J. E. Galan. 2004. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 304:1805–1807.[PubMed] [CrossRef]
102. Hernandez, L. D., M. Pypaert, R. A. Flavell, and J. E. Galan. 2003. A Salmonella protein causes macrophage cell death by inducing autophagy. J. Cell Biol. 163:1123–1131.[PubMed] [CrossRef]
103. Hersh, D., D. M. Monack, M. R. Smith, N. Ghori, S. Falkow, and A. Zychlinsky. 1999. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc. Natl. Acad. Sci. USA 96:2396–2401.[PubMed] [CrossRef]
104. Hobbie, S., L. M. Chen, R. J. Davis, and J. E. Galan. 1997. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J. Immunol. 159:5550–5559.[PubMed]
105. Holden, D. W. 2002. Trafficking of the Salmonella vacuole in macrophages. Traffic 3:161–169.[PubMed] [CrossRef]
106. Hueck, C. J. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379–433.[PubMed]
107. Hueffer, K., and J. E. Galan. 2004. Salmonella-induced macrophage death: multiple mechanisms, different outcomes. Cell. Microbiol. 6:1019–1025.[PubMed] [CrossRef]
108. Ishibashi, Y., and T. Arai. 1990. Specific inhibition of phagosome-lysosome fusion in murine macrophages mediated by Salmonella typhimurium infection. FEMS Microbiol. Immunol. 2:35–43.[PubMed] [CrossRef]
109. Jabado, N., P. Cuellar-Mata, S. Grinstein, and P. Gros. 2003. Iron chelators modulate the fusogenic properties of Salmonella-containing phagosomes. Proc. Natl. Acad. Sci. USA 100:6127–6132.[PubMed] [CrossRef]
110. Jabado, N., A. Jankowski, S. Dougaparsad, V. Picard, S. Grinstein, and P. Gros. 2000. Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J. Exp. Med. 192:1237–1248.[PubMed] [CrossRef]
111. Jantsch, J., C. Cheminay, D. Chakravortty, T. Lindig, J. Hein, and M. Hensel. 2003. Intracellular activities of Salmonella enterica in murine dendritic cells. Cell. Microbiol. 5:933–945.[PubMed] [CrossRef]
112. Jarvelainen, H. A., A. Galmiche, and A. Zychlinsky. 2003. Caspase-1 activation by Salmonella. Trends Cell Biol. 13:204–209.[PubMed] [CrossRef]
113. Jesenberger, V., K. J. Procyk, J. Yuan, S. Reipert, and M. Baccarini. 2000. Salmonella-induced caspase-2 activation in macrophages: a novel mechanism in pathogen-mediated apoptosis. J. Exp. Med. 192:1035–1046.[PubMed] [CrossRef]
114. Jiang, X., O. W. Rossanese, N. F. Brown, S. Kujat-Choy, J. E. Galan, B. B. Finlay, and J. H. Brumell. 2004. The related effector proteins SopD and SopD2 from Salmonella enterica serovar Typhimurium contribute to virulence during systemic infection of mice. Mol. Microbiol. 54:1186–1198.[PubMed] [CrossRef]
115. Jones, B. D., and S. Falkow. 1996. Salmonellosis: host immune responses and bacterial virulence determinants. Annu. Rev. Immunol. 14:533–561.[PubMed] [CrossRef]
116. Jones, M. A., M. W. Wood, P. B. Mullan, P. R. Watson, T. S. Wallis, and E. E. Galyov. 1998. Secreted effector proteins of Salmonella dublin act in concert to induce enteritis. Infect. Immun. 66:5799–5804.[PubMed]
117. Jordens, I., M. Fernandez-Borja, M. Marsman, S. Dusseljee, L. Janssen, J. Calafat, H. Janssen, R. Wubbolts, and J. Neefjes. 2001. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr. Biol. 11:1680–1685.[PubMed] [CrossRef]
118. Jost, M., F. Simpson, J. M. Kavran, M. A. Lemmon, and S. L. Schmid. 1998. Phosphatidylinositol-4,5-bisphosphate is required for endocytic coated vesicle formation. Curr. Biol. 8:1399–1402.[PubMed] [CrossRef]
119. Klein, J. R., and B. D. Jones. 2001. Salmonella pathogenicity island 2-encoded proteins SseC and SseD are essential for virulence and are substrates of the type III secretion system. Infect. Immun. 69:737–743.[PubMed] [CrossRef]
120. Knodler, L. A., J. Celli, W. D. Hardt, B. A. Vallance, C. Yip, and B. B. Finlay. 2002. Salmonella effectors within a single pathogenicity island are differentially expressed and translocated by separate type III secretion systems. Mol. Microbiol. 43:1089–1103.[PubMed] [CrossRef]
121. Knodler, L. A., and B. B. Finlay. 2001. Salmonella and apoptosis: to live or let die? Microb. Infect. 3:1321–1326. [CrossRef]
122. Knodler, L. A., B. B. Finlay, and O. Steele-Mortimer. 2005. The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt. J. Biol. Chem. 280:9058-9064. [CrossRef]
123. Knodler, L. A., and O. Steele-Mortimer. 2003. Taking possession: biogenesis of the Salmonella-containing vacuole. Traffic 4:587–599.[PubMed] [CrossRef]
124. Knodler, L. A., B. A. Vallance, M. Hensel, D. Jackel, B. B. Finlay, and O. Steele-Mortimer. 2003. Salmonella type III effectors PipB and PipB2 are targeted to detergent-resistant microdomains on internal host cell membranes. Mol. Microbiol. 49:685–704.[PubMed] [CrossRef]
125. Kubori, T., and J. E. Galan. 2003. Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115:333–342.[PubMed] [CrossRef]
126. Kubori, T., Y. Matsushima, D. Nakamura, J. Uralil, M. Lara-Tejero, A. Sukhan, J. E. Galan, and S. I. Aizawa. 1998. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 280:602–605.[PubMed] [CrossRef]
127. Kubori, T., A. Sukhan, S. I. Aizawa, and J. E. Galan. 2000. Molecular characterization and assembly of the needle complex of the Salmonella typhimurium type III protein secretion system. Proc. Natl. Acad. Sci. USA 97:10225–10230.[PubMed] [CrossRef]
128. Kuhle, V., and M. Hensel. 2002. SseF and SseG are translocated effectors of the type III secretion system of Salmonella pathogenicity island 2 that modulate aggregation of endosomal compartments. Cell. Microbiol. 4:813–824.[PubMed] [CrossRef]
129. Kuhle, V., D. Jackel, and M. Hensel. 2004. Effector proteins encoded by salmonella pathogenicity island 2 interfere with the microtubule cytoskeleton after translocation into host cells. Traffic 5:356–370.[PubMed] [CrossRef]
130. Kujat Choy, S. L., E. C. Boyle, O. Gal-Mor, D. L. Goode, Y. Valdez, B. A. Vallance, and B. B. Finlay. 2004. SseK1 and SseK2 are novel translocated proteins of Salmonella enterica serovar typhimurium. Infect. Immun. 72:5115–5125.[PubMed] [CrossRef]
131. Kurita, A., H. Gotoh, M. Eguchi, N. Okada, S. Matsuura, H. Matsui, H. Danbara, and Y. Kikuchi. 2003. Intracellular expression of the Salmonella plasmid virulence protein, SpvB, causes apoptotic cell death in eukaryotic cells. Microb. Pathog. 35:43–48.[PubMed] [CrossRef]
131a. Layton, A. N., P. J. Brown, and E. E. Galyov. 2005. The Salmonella translocated effector SopA is targeted to the mitochondria of infected cells. J. Bacteriol. 187:3565-3571. [CrossRef]
132. Lee, A. H., M. P. Zareei, and S. Daefler. 2002. Identification of a NIPSNAP homologue as host cell target for Salmonella virulence protein SpiC. Cell. Microbiol. 4:739–750.[PubMed] [CrossRef]
133. Lee, A. K., C. S. Detweiler, and S. Falkow. 2000. OmpR regulates the two-component system SsrA-ssrB in Salmonella pathogenicity island 2. J. Bacteriol. 182:771–781.[PubMed] [CrossRef]
134. Lesnick, M. L., N. E. Reiner, J. Fierer, and D. G. Guiney. 2001. The Salmonella spvB virulence gene encodes an enzyme that ADP-ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells. Mol. Microbiol. 39:1464–1470.[PubMed] [CrossRef]
135. Libby, S. J., W. Goebel, A. Ludwig, N. Buchmeier, F. Bowe, F. C. Fang, D. G. Guiney, J. G. Songer, and F. Heffron. 1994. A cytolysin encoded by Salmonella is required for survival within macrophages. Proc. Natl. Acad. Sci. USA 91:489–493.[PubMed] [CrossRef]
136. Lilic, M., V. E. Galkin, A. Orlova, M. S. VanLoock, E. H. Egelman, and C. E. Stebbins. 2003. Salmonella SipA polymerizes actin by stapling filaments with nonglobular protein arms. Science 301:1918–1921.[PubMed] [CrossRef]
137. Lindquist, B. L., E. Lebenthal, P. C. Lee, M. W. Stinson, and J. M. Merrick. 1987. Adherence of Salmonella typhimurium to small-intestinal enterocytes of the rat. Infect. Immun. 55:3044–3050.[PubMed]
138. Lo, W. F., H. Ong, E. S. Metcalf, and M. J. Soloski. 1999. T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 162:5398–5406.[PubMed]
139. Maksymowych, W. P., and K. P. Kane. 2000. Bacterial modulation of antigen processing and presentation. Microb. Infect. 2:199–211. [CrossRef]
140. Malik, P., V. D. Sharma, and D. C. Thapliyal. 1996. Partial purification and characterization of Salmonella cytotoxin. Vet. Microbiol. 49:11–19.[PubMed] [CrossRef]
141. Marcus, S. L., J. H. Brumell, C. G. Pfeifer, and B. B. Finlay. 2000. Salmonella pathogenicity islands: big virulence in small packages. Microb. Infect. 2:145–156. [CrossRef]
142. Marcus, S. L., M. R. Wenk, O. Steele-Mortimer, and B. B. Finlay. 2001. A synaptojanin-homologous region of Salmonella typhimurium SigD is essential for inositol phosphatase activity and Akt activation. FEBS Lett. 494:201–207.[PubMed] [CrossRef]
143. Marlovits, T. C., T. Kubori, A. Sukhan, D. R. Thomas, J. E. Galan, and V. M. Unger. 2004. Structural insights into the assembly of the type III secretion needle complex. Science 306:1040–1042.[PubMed] [CrossRef]
144. Marsman, M., I. Jordens, C. Kuijl, L. Janssen, and J. Neefjes. 2004. Dynein-mediated vesicle transport controls intracellular Salmonella replication. Mol. Biol. Cell 15:2954–2964.[PubMed] [CrossRef]
145. Mastroeni, P., and M. Sheppard. 2004. Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues. Microb. Infect. 6:398–405. [CrossRef]
146. McCormick, B. A., S. P. Colgan, C. Delp-Archer, S. I. Miller, and J. L. Madara. 1993. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J. Cell Biol. 123:895–907.[PubMed] [CrossRef]
147. McCormick, B. A., S. I. Miller, D. Carnes, and J. L. Madara. 1995. Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis. Infect. Immun. 63:2302–2309.[PubMed]
148. McCormick, B. A., C. A. Parkos, S. P. Colgan, D. K. Carnes, and J. L. Madara. 1998. Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. J. Immunol. 160:455–466.[PubMed]
149. McGhie, E. J., R. D. Hayward, and V. Koronakis. 2004. Control of actin turnover by a salmonella invasion protein. Mol. Cell 13:497–510.[PubMed] [CrossRef]
150. McGhie, E. J., R. D. Hayward, and V. Koronakis. 2001. Cooperation between actin-binding proteins of invasive Salmonella: SipA potentiates SipC nucleation and bundling of actin. EMBO J. 20:2131–2139.[PubMed] [CrossRef]
151. Meresse, S., O. Steele-Mortimer, B. B. Finlay, and J. P. Gorvel. 1999. The rab7 GTPase controls the maturation of Salmonella typhimurium-containing vacuoles in HeLa cells. EMBO J. 18:4394–4403.[PubMed] [CrossRef]
152. Meresse, S., K. E. Unsworth, A. Habermann, G. Griffiths, F. Fang, M. J. Martinez-Lorenzo, S. R. Waterman, J. P. Gorvel, and D. W. Holden. 2001. Remodelling of the actin cytoskeleton is essential for replication of intravacuolar Salmonella. Cell. Microbiol. 3:567–577.[PubMed] [CrossRef]
153. Meyerholz, D. K., T. J. Stabel, M. R. Ackermann, S. A. Carlson, B. D. Jones, and J. Pohlenz. 2002. Early epithelial invasion by Salmonella enterica serovar Typhimurium DT104 in the swine ileum. Vet. Pathol. 39:712–720.[PubMed] [CrossRef]
154. Miao, E. A., M. Brittnacher, A. Haraga, R. L. Jeng, M. D. Welch, and S. I. Miller. 2003. Salmonella effectors translocated across the vacuolar membrane interact with the actin cytoskeleton. Mol. Microbiol. 48:401–415.[PubMed] [CrossRef]
155. Miao, E. A., J. A. Freeman, and S. I. Miller. 2002. Transcription of the SsrAB regulon is repressed by alkaline pH and is independent of PhoPQ and magnesium concentration. J. Bacteriol. 184:1493–1497.[PubMed] [CrossRef]
156. Miao, E. A., and S. I. Miller. 2000. A conserved amino acid sequence directing intracellular type III secretion by Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 97:7539–7544.[PubMed] [CrossRef]
157. Miao, E. A., C. A. Scherer, R. M. Tsolis, R. A. Kingsley, L. G. Adams, A. J. Baumler, and S. I. Miller. 1999. Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems. Mol. Microbiol. 34:850–864.[PubMed] [CrossRef]
158. Mills, S. D., and B. B. Finlay. 1998. Isolation and characterization of Salmonella typhimurium- and Yersinia pseudotuberculosis-containing phagosomes from infected mouse macrophages: Y. pseudotuberculosis traffics to terminal lysosomes where they are degraded. Eur. J. Cell Biol. 77:35–47.[PubMed]
159. Mitchell, E. K., P. Mastroeni, A. P. Kelly, and J. Trowsdale. 2004. Inhibition of cell surface MHC class II expression by Salmonella. Eur. J. Immunol. 34:2559–2567.[PubMed] [CrossRef]
160. Mitra, K., D. Zhou, and J. E. Galan. 2000. Biophysical characterization of SipA, an actin-binding protein from Salmonella enterica. FEBS Lett. 482:81–84.[PubMed] [CrossRef]
161. Monack, D. M., D. M. Bouley, and S. Falkow. 2004. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFN gamma neutralization. J. Exp. Med. 199:231–241.[PubMed] [CrossRef]
162. Monack, D. M., C. S. Detweiler, and S. Falkow. 2001. Salmonella pathogenicity island 2-dependent macrophage death is mediated in part by the host cysteine protease caspase-1. Cell. Microbiol. 3:825–837.[PubMed] [CrossRef]
163. Monack, D. M., D. Hersh, N. Ghori, D. Bouley, A. Zychlinsky, and S. Falkow. 2000. Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model. J. Exp. Med. 192:249–258.[PubMed] [CrossRef]
164. Monack, D. M., W. W. Navarre, and S. Falkow. 2001. Salmonella-induced macrophage death: the role of caspase-1 in death and inflammation. Microb. Infect. 3:1201–1212. [CrossRef]
165. Monack, D. M., B. Raupach, A. E. Hromockyj, and S. Falkow. 1996. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc. Natl. Acad. Sci. USA 93:9833–9838.[PubMed] [CrossRef]
166. Mukherjee, K., S. A. Siddiqi, S. Hashim, M. Raje, S. K. Basu, and A. Mukhopadhyay. 2000. Live Salmonella recruits N-ethylmaleimide-sensitive fusion protein on phagosomal membrane and promotes fusion with early endosome. J. Cell Biol. 148:741–753.[PubMed] [CrossRef]
167. Niedergang, F., A. Didierlaurent, J. P. Kraehenbuhl, and J. C. Sirard. 2004. Dendritic cells: the host Achille's heel for mucosal pathogens? Trends Microbiol. 12:79–88.[PubMed] [CrossRef]
168. Nikolaus, T., J. Deiwick, C. Rappl, J. A. Freeman, W. Schroder, S. I. Miller, and M. Hensel. 2001. SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon. J. Bacteriol. 183:6036–6045.[PubMed] [CrossRef]
169. Norris, F. A., M. P. Wilson, T. S. Wallis, E. E. Galyov, and P. W. Majerus. 1998. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase [see comments]. Proc. Natl. Acad. Sci. USA 95:14057–14059.[PubMed] [CrossRef]
170. Obregon, C., D. Dreher, M. Kok, L. Cochand, G. S. Kiama, and L. P. Nicod. 2003. Human alveolar macrophages infected by virulent bacteria expressing SipB are a major source of active interleukin-18. Infect. Immun. 71:4382–4388.[PubMed] [CrossRef]
171. Ochman, H., and E. A. Groisman. 1996. Distribution of pathogenicity islands in Salmonella spp. Infect. Immun. 64:5410–5412.[PubMed]
172. Ochman, H., F. C. Soncini, F. Solomon, and E. A. Groisman. 1996. Identification of a pathogenicity island required for Salmonella survival in host cells. Proc. Natl. Acad. Sci. USA 93:7800–7804.[PubMed] [CrossRef]
173. Oh, Y. K., C. Alpuche-Aranda, E. Berthiaume, T. Jinks, S. I. Miller, and J. A. Swanson. 1996. Rapid and complete fusion of macrophage lysosomes with phagosomes containing Salmonella typhimurium. Infect. Immun. 64:3877–3883.[PubMed]
174. Pace, J., M. J. Hayman, and J. E. Galan. 1993. Signal transduction and invasion of epithelial cells by S. typhimurium. Cell 72:505–514.[PubMed] [CrossRef]
175. Parsot, C., C. Hamiaux, and A. L. Page. 2003. The various and varying roles of specific chaperones in type III secretion systems. Curr. Opin. Microbiol. 6:7–14.[PubMed] [CrossRef]
176. Pattni, K., M. Jepson, H. Stenmark, and G. Banting. 2001. A PtdIns(3)P-specific probe cycles on and off host cell membranes during Salmonella invasion of mammalian cells. Curr. Biol. 11:1636–1642.[PubMed] [CrossRef]
177. Perrin, A. J., X. Jiang, C. L. Birmingham, N. S. So, and J. H. Brumell. 2004. Recognition of bacteria in the cytosol of mammalian cells by the ubiquitin system. Curr. Biol. 14:806–811.[PubMed] [CrossRef]
178. Petrovska, L., R. J. Aspinall, L. Barber, S. Clare, C. P. Simmons, R. Stratford, S. A. Khan, N. R. Lemoine, G. Frankel, D. W. Holden, and G. Dougan. 2004. Salmonella enterica serovar Typhimurium interaction with dendritic cells: impact of the sifA gene. Cell. Microbiol. 6:1071–1084.[PubMed] [CrossRef]
179. Pfeifer, C. G., S. L. Marcus, O. Steele-Mortimer, L. A. Knodler, and B. B. Finlay. 1999. Salmonella typhimurium virulence genes are induced upon bacterial invasion into phagocytic and nonphagocytic cells. Infect. Immun. 67:5690–5698.[PubMed]
180. Qimron, U., N. Madar, H. W. Mittrucker, A. Zilka, I. Yosef, N. Bloushtain, S. H. Kaufmann, I. Rosenshine, R. N. Apte, and A. Porgador. 2004. Identification of Salmonella typhimurium genes responsible for interference with peptide presentation on MHC class I molecules: Deltayej Salmonella mutants induce superior CD8+ T-cell responses. Cell. Microbiol. 6:1057–1070.[PubMed] [CrossRef]
181. Raffatellu, M., R. P. Wilson, D. Chessa, H. Andrews-Polymenis, Q. T. Tran, S. Lawhon, S. Khare, L. G. Adams, and A. J. Baumler. 2005. SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype typhimurium invasion of epithelial cells. Infect. Immun. 73:146–154.[PubMed] [CrossRef]
182. Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:361–367.[PubMed] [CrossRef]
183. Richter-Dahlfors, A., A. M. J. Buchan, and B. B. Finlay. 1997. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J. Exp. Med. 186:569–580.[PubMed] [CrossRef]
184. Rosenshine, I., S. Ruschkowski, V. Foubister, and B. B. Finlay. 1994. Salmonella typhimurium invasion of epithelial cells: role of induced host cell tyrosine protein phosphorylation. Infect. Immun. 62:4969–4974.[PubMed]
185. Rudolph, M. G., C. Weise, S. Mirold, B. Hillenbrand, B. Bader, A. Wittinghofer, and W. D. Hardt. 1999. Biochemical analysis of SopE from Salmonella typhimurium, a highly efficient guanosine nucleotide exchange factor for RhoGTPases. J. Biol. Chem. 274:30501–30509.[PubMed] [CrossRef]
186. Ruiz-Albert, J., X. J. Yu, C. R. Beuzon, A. N. Blakey, E. E. Galyov, and D. W. Holden. 2002. Complementary activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar membrane. Mol. Microbiol. 44:645–661.[PubMed] [CrossRef]
187. Rumeu, M. T., M. A. Suarez, S. Morales, and R. Rotger. 1997. Enterotoxin and cytotoxin production by Salmonella enteritidis strains isolated from gastroenteritis outbreaks. J. Appl. Microbiol. 82:19–31.[PubMed] [CrossRef]
188. Salcedo, S. P., and D. W. Holden. 2003. SseG, a virulence protein that targets Salmonella to the Golgi network. EMBO J. 22:5003–5014.[PubMed] [CrossRef]
189. Salcedo, S. P., M. Noursadeghi, J. Cohen, and D. W. Holden. 2001. Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo. Cell. Microbiol. 3:587–597.[PubMed] [CrossRef]
190. Scherer, C. A., E. Cooper, and S. I. Miller. 2000. The Salmonella type III secretion translocon protein SspC is inserted into the epithelial cell plasma membrane upon infection. Mol. Microbiol. 37:1133–1145.[PubMed] [CrossRef]
191. Scott, C. C., P. Cuellar-Mata, T. Matsuo, H. W. Davidson, and S. Grinstein. 2002. Role of 3-phosphoinositides in the maturation of Salmonella-containing vacuoles within host cells. J. Biol. Chem. 277:12770–12776.[PubMed] [CrossRef]
192. Shea, J. E., M. Hensel, C. Gleeson, and D. W. Holden. 1996. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 93:2593–2597.[PubMed] [CrossRef]
193. Shi, Y., M. J. Cromie, F. F. Hsu, J. Turk, and E. A. Groisman. 2004. PhoP-regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B. Mol. Microbiol. 53:229–241.[PubMed] [CrossRef]
194. Shi, Y., T. Latifi, M. J. Cromie, and E. A. Groisman. 2004. Transcriptional control of the antimicrobial peptide resistance ugtL gene by the Salmonella PhoP and SlyA regulatory proteins. J. Biol. Chem. 279:38618–38625.[PubMed] [CrossRef]
195. Shotland, Y., H. Kramer, and E. A. Groisman. 2003. The Salmonella SpiC protein targets the mammalian Hook3 protein function to alter cellular trafficking. Mol. Microbiol. 49:1565–1576.[PubMed] [CrossRef]
196. Siebers, A., and B. B. Finlay. 1996. M cells and the pathogenesis of mucosal and systemic infections. Trends Microbiol. 4:22–29.[PubMed] [CrossRef]
197. Steele-Mortimer, O., J. H. Brumell, L. A. Knodler, S. Meresse, A. Lopez, and B. B. Finlay. 2002. The invasion-associated type III secretion system of Salmonella enterica serovar Typhimurium is necessary for intracellular proliferation and vacuole biogenesis in epithelial cells. Cell. Microbiol. 4:43–54.[PubMed] [CrossRef]
198. Steele-Mortimer, O., L. A. Knodler, S. L. Marcus, M. P. Scheid, B. Goh, C. G. Pfeifer, V. Duronio, and B. B. Finlay. 2000. Activation of Akt/protein kinase B in epithelial cells by the Salmonella typhimurium effector sigD. J. Biol. Chem. 275:37718–37724.[PubMed] [CrossRef]
199. Steele-Mortimer, O., S. Méresse, J.-P. Gorvel, B.-H. Toh, and B. B. Finlay. 1999. Biogenesis of Salmonella typhimurium-containing vacuoles in epithelial cells involves interactions with the early endocytic pathway. Cell. Microbiol. 1:33–51.[PubMed] [CrossRef]
200. Stein, M. A., K. Y. Leung, M. Zwick, F. Garcia-del Portillo, and B. B. Finlay. 1996. Identification of a Salmonella virulence gene required for formation of filamentous structures containing lysosomal membrane glycoproteins within epithelial cells. Mol. Microbiol. 20:151–164.[PubMed] [CrossRef]
201. Stender, S., A. Friebel, S. Linder, M. Rohde, S. Mirold, and W. D. Hardt. 2000. Identification of SopE2 from Salmonella typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell. Mol. Microbiol. 36:1206–1221.[PubMed] [CrossRef]
202. Sukhan, A., T. Kubori, and J. E. Galan. 2003. Synthesis and localization of the Salmonella SPI-1 type III secretion needle complex proteins PrgI and PrgJ. J. Bacteriol. 185:3480–3483.[PubMed] [CrossRef]
203. Sukhan, A., T. Kubori, J. Wilson, and J. E. Galan. 2001. Genetic analysis of assembly of the Salmonella enterica serovar Typhimurium type III secretion-associated needle complex. J. Bacteriol. 183:1159–1167.[PubMed] [CrossRef]
204. Sundquist, M., A. Rydstrom, and M. J. Wick. 2004. Immunity to Salmonella from a dendritic point of view. Cell. Microbiol. 6:1–11.[PubMed] [CrossRef]
205. Takaya, A., A. Suzuki, Y. Kikuchi, M. Eguchi, E. Isogai, T. Tomoyasu, and T. Yamamoto. 2005. Derepression of Salmonella pathogenicity island 1 genes within macrophages leads to rapid apoptosis via caspase-1- and caspase-3-dependent pathways. Cell. Microbiol. 7:79–90.[PubMed] [CrossRef]
206. Takenawa, T., and T. Itoh. 2001. Phosphoinositides, key molecules for regulation of actin cytoskeletal organization and membrane traffic from the plasma membrane. Biochim. Biophys. Acta 1533:190–206.[PubMed]
207. Takeuchi, A. 1967. Electron microscope studies of experimental Salmonella infection. I. Penetration into the intestinal epithelium by Salmonella typhimurium. Am. J. Pathol. 50:109–136.[PubMed]
208. Terebiznik, M. R., O. V. Vieira, S. L. Marcus, A. Slade, C. M. Yip, W. S. Trimble, T. Meyer, B. B. Finlay, and S. Grinstein. 2002. Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat. Cell Biol. 4:766–773.[PubMed] [CrossRef]
209. Tezcan-Merdol, D., T. Nyman, U. Lindberg, F. Haag, F. Koch-Nolte, and M. Rhen. 2001. Actin is ADP-ribosylated by the Salmonella enterica virulence-associated protein SpvB. Mol. Microbiol. 39:606–619.[PubMed] [CrossRef]
210. Tsolis, R. M., R. A. Kingsley, S. M. Townsend, T. A. Ficht, L. G. Adams, and A. J. Baumler. 1999. Of mice, calves, and men. Comparison of the mouse typhoid model with other Salmonella infections. Adv. Exp. Med. Biol. 473:261–274.[PubMed]
211. Tsolis, R. M., S. M. Townsend, E. A. Miao, S. I. Miller, T. A. Ficht, L. G. Adams, and A. J. Baumler. 1999. Identification of a putative Salmonella enterica serotype typhimurium host range factor with homology to IpaH and YopM by signature-tagged mutagenesis. Infect. Immun. 67:6385–6393.[PubMed]
212. Tucker, S. C., and J. E. Galan. 2000. Complex function for SicA, a Salmonella enterica serovar typhimurium type III secretion-associated chaperone. J. Bacteriol. 182:2262–2268.[PubMed] [CrossRef]
213. Uchiya, K., M. A. Barbieri, K. Funato, A. H. Shah, P. D. Stahl, and E. A. Groisman. 1999. A Salmonella virulence protein that inhibits cellular trafficking. EMBO J. 18:3924–3933.[PubMed] [CrossRef]
214. Unsworth, K. E., M. Way, M. McNiven, L. Machesky, and D. W. Holden. 2004. Analysis of the mechanisms of Salmonella-induced actin assembly during invasion of host cells and intracellular replication. Cell. Microbiol. 6:1041–1055.[PubMed] [CrossRef]
215. van der Velden, A. W., S. W. Lindgren, M. J. Worley, and F. Heffron. 2000. Salmonella pathogenicity island 1-independent induction of apoptosis in infected macrophages by Salmonella enterica serotype typhimurium. Infect. Immun. 68:5702–5709.[PubMed] [CrossRef]
216. van der Velden, A. W., M. Velasquez, and M. N. Starnbach. 2003. Salmonella rapidly kill dendritic cells via a caspase-1-dependent mechanism. J. Immunol. 171:6742–6749.[PubMed]
217. Vazquez-Torres, A., J. Jones-Carson, A. J. Baumler, S. Falkow, R. Valdivia, W. Brown, M. Le, R. Berggren, W. T. Parks, and F. C. Fang. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804–808.[PubMed] [CrossRef]
218. Vazquez-Torres, A., Y. Xu, J. Jones-Carson, D. W. Holden, S. M. Lucia, M. C. Dinauer, P. Mastroeni, and F. C. Fang. 2000. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287:1655–1658.[PubMed] [CrossRef]
219. Veiga, E., and P. Cossart. 2005. Ubiquitination of intracellular bacteria: a new bacteria-sensing system? Trends Cell Biol. 15:2–5.[PubMed] [CrossRef]
220. Vidal, S., P. Gros, and E. Skamene. 1995. Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus. J. Leukoc. Biol. 58:382–390.[PubMed]
221. Vieira, O. V., R. J. Botelho, and S. Grinstein. 2002. Phagosome maturation: aging gracefully. Biochem. J. 366:689–704.[PubMed]
222. Waterman, S. R., and D. W. Holden. 2003. Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cell. Microbiol. 5:501–511.[PubMed] [CrossRef]
223. Watson, P. R., A. V. Gautier, S. M. Paulin, A. P. Bland, P. W. Jones, and T. S. Wallis. 2000. Salmonella enterica serovars Typhimurium and Dublin can lyse macrophages by a mechanism distinct from apoptosis. Infect. Immun. 68:3744–3747.[PubMed] [CrossRef]
224. Wick, M. J. 2002. The role of dendritic cells during Salmonella infection. Curr. Opin. Immunol. 14:437–443.[PubMed] [CrossRef]
225. Wick, M. J., C. V. Harding, N. J. Twesten, S. J. Normark, and J. D. Pfeifer. 1995. The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Mol. Microbiol. 16:465–476.[PubMed] [CrossRef]
226. Williams, C., E. E. Galyov, and S. Bagby. 2004. Solution structure, backbone dynamics, and interaction with Cdc42 of Salmonella guanine nucleotide exchange factor SopE2. Biochemistry 43:11998–12008.[PubMed] [CrossRef]
227. Wong, K. K., M. McClelland, L. C. Stillwell, E. C. Sisk, S. J. Thurston, and J. D. Saffer. 1998. Identification and sequence analysis of a 27-kilobase chromosomal fragment containing a Salmonella pathogenicity island located at 92 minutes on the chromosome map of Salmonella enterica serovar typhimurium LT2. Infect. Immun. 66:3365–3371.[PubMed]
228. Wood, M. W., M. A. Jones, P. R. Watson, A. M. Siber, B. A. McCormick, S. Hedges, R. Rosqvist, T. S. Wallis, and E. E. Galyov. 2000. The secreted effector protein of Salmonella dublin, SopA, is translocated into eukaryotic cells and influences the induction of enteritis. Cell. Microbiol. 2:293–303.[PubMed] [CrossRef]
229. Yin, H. L., and P. A. Janmey. 2003. Phosphoinositide regulation of the actin cytoskeleton. Annu. Rev. Physiol. 65:761–789.[PubMed] [CrossRef]
230. Yrlid, U., and M. J. Wick. 2000. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. 191:613–624.[PubMed] [CrossRef]
231. Yu, X. J., J. Ruiz-Albert, K. E. Unsworth, S. Garvis, M. Liu, and D. W. Holden. 2002. SpiC is required for secretion of Salmonella Pathogenicity Island 2 type III secretion system proteins. Cell. Microbiol. 4:531–540.[PubMed] [CrossRef]
232. Zaharik, M. L., B. A. Vallance, J. L. Puente, P. Gros, and B. B. Finlay. 2002. Host-pathogen interactions: host resistance factor Nramp1 up-regulates the expression of Salmonella pathogenicity island-2 virulence genes. Proc. Natl. Acad. Sci. USA 99:15705–15710.[PubMed] [CrossRef]
233. Zhang, S., R. L. Santos, R. M. Tsolis, S. Stender, W. D. Hardt, A. J. Baumler, and L. G. Adams. 2002. The Salmonella enterica serotype typhimurium effector proteins SipA, SopA, SopB, SopD, and SopE2 act in concert to induce diarrhea in calves. Infect. Immun. 70:3843–3855.[PubMed] [CrossRef]
234. Zhou, D., L. M. Chen, L. Hernandez, S. B. Shears, and J. E. Galan. 2001. A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol. Microbiol. 39:248–259.[PubMed] [CrossRef]
235. Zhou, D., M. S. Mooseker, and J. E. Galan. 1999. An invasion-associated Salmonella protein modulates the actin-bundling activity of plastin. Proc. Natl. Acad. Sci. USA 96:10176–10181.[PubMed] [CrossRef]
236. Zhou, D., M. S. Mooseker, and J. E. Galan. 1999. An invasion-associated Salmonella protein modulates the actin-bundling activity of plastin. Proc. Natl. Acad. Sci. USA 96:10176–10181.[PubMed] [CrossRef]
237. Zhou, D., M. S. Mooseker, and J. E. Galan. 1999. Role of the S. typhimurium actin-binding protein SipA in bacterial internalization. Science 283:2092–2095.[PubMed] [CrossRef]